Detection and serotyping of foot-and-mouth disease virus with laboratory and in silico methods by Ortega Polo, Rodrigo & University of Lethbridge. Faculty of Arts and Science
University of Lethbridge Research Repository
OPUS http://opus.uleth.ca
Theses Arts and Science, Faculty of
2018
Detection and serotyping of
foot-and-mouth disease virus with
laboratory and in silico methods
Ortega Polo, Rodrigo
Lethbridge, Alta. : Universtiy of Lethbridge, Department of Biological Sciences
https://hdl.handle.net/10133/5257
Downloaded from University of Lethbridge Research Repository, OPUS
DETECTION AND SEROTYPING OF FOOT-AND-MOUTH DISEASE VIRUS
WITH LABORATORY AND IN SILICO METHODS
RODRIGO ORTEGA POLO
Bachelor of Science, University of Lethbridge, 2011
A Thesis
Submitted to the School of Graduate Studies
of the University of Lethbridge
in Partial Fulfillment of the
Requirements for the Degree
MASTER OF SCIENCE
Department of Biological Sciences
University of Lethbridge
LETHBRIDGE, ALBERTA, CANADA
c© Rodrigo Ortega Polo, 2018
DETECTION AND SEROTYPING OF FOOT-AND-MOUTH DISEASE VIRUS WITH
LABORATORY AND IN SILICO METHODS
RODRIGO ORTEGA POLO
Date of Defense: July 16, 2018
Dr. O. Lung
Co-Supervisor Adjunct Professor Ph.D.
Dr. R.M. Golsteyn
Co-Supervisor Associate Professor Ph.D.
Dr. C.P. Goater
Committee Member Professor Ph.D.
Dr. E. Taboada
Committee Member Adjunct Professor Ph.D.
Dr. I. Kovalchuk
Examination Chair Professor Ph.D./M.D.
Abstract
Foot-and-mouth disease virus (FMDV) is a highly contagious animal pathogen and it has
a variable genome and high antigenic variation. There are seven known serotypes of this
virus: A, O, C, Asia1, SAT1, SAT2, and SAT3. The rapid detection and serotype charac-
terization of the virus is instrumental for the prompt response by animal health authorities.
This thesis presents the design and development of the first electronic microarray assay
for the simultaneous detection and subtyping of FMDV. The assay was evaluated in silico
and it was tested with 19 synthetic DNA constructs representing all 7 serotypes, followed
by the testing with 23 viral RNA samples representing all 7 serotypes. Also, various in
silico methods were compared for the classification of FMDV sequences using complete
genomes and next generation sequencing (NGS) data. Finally, highly specific and highly
sensitive single nucleotide variant signatures that distinguish the seven FMDV serotypes
were discovered.
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Chapter 1
Literature Review
1.1 Abstract
Transboundary and Emerging Diseases (TBED) are a concern for human and animal
health authorities around the world. A critical component to the response of those dis-
eases is the detection methodology used for establishing the presence of their causative
pathogens. A large number of serology and molecular biology methods have been devel-
oped and updated to detect and differentiate pathogens. Due to their higher throughput and
increased automation, microarrays were once considered as viable alternative methods to
more traditional techniques to detect and differentiate pathogens. Microarrays proved to be
valuable in cases where diagnosis was not possible with other techniques or in the devel-
opment of tools designed to detect a large number of genera of bacteria and viruses. The
following review will present the state of the art in molecular testing microarrays for detec-
tion and subtyping of pathogens. Examples from human and veterinary diagnostics will be
discussed, and a strong emphasis will be placed in the history of detection and serotyping
methods for FMDV, a highly contagious and highly variable pathogen of cloven-hoofed an-
imals. The advances in microarray technologies here reviewed are presented in the context
of the recent increase in prevalence and affordability of next generation sequencing.
1.2 Transboundary and emerging infectious diseases of animals
Infectious diseases that appear for the first time or reappear in a population are known
as emergent and infectious diseases (EID), and their impact on human and animal health
1
1.2. TRANSBOUNDARY AND EMERGING INFECTIOUS DISEASES OF ANIMALS
are an important issue for the general population and governments around the world. No-
table outbreaks of EIDs have elicited the action of international human and animal health
authorities in several occasions (Table 1.1). The mechanisms by which infectious diseases
can emerge are diverse and complex, and thus present challenges to governments and inter-
national organizations in the management and control of infectious diseases.
1.2.1 Mechanisms of emergence of viral diseases
The emergence of infectious diseases can be influenced by the dynamics of the ecology
and biology of the host, the pathogen, or both. Examples of important ecological factors
that influence the emergence of diseases are the rapid growth of human populations, spill-
over effects and climate change (Daszak et al., 2000). Examples of biological factors that
shape the emergence of infectious diseases are the evolution of viruses, and the response
of the host immune system to infection. In the case of viral evolution, emergent viruses
can arise by processes known as antigenic drift and antigenic shift. Antigenic drift occurs
when mutations in the genes of viruses accumulate over time as the viruses replicate. This
results in viruses that are phylogenetically related and show the same antigenic properties.
Antigenic shift is a sudden change in the viral genomes that results in new infectious prop-
erties. A clear example of this was the H1N1 pandemic where reassortment of the influenza
genome resulted in the transmission of highly virulent strains.
1.2.2 Policies and government-led actions
The mitigation of outbreaks of emergent zoonotic (diseases that are transmitted from
animals to humans) and animal infectious diseases have required the collaboration between
international organizations such as the World Health Organization, the World Organization
for Animal Health (OIE)1, and the Food and Agriculture Organization of the United Nations
(FAO) to mitigate the impact of those events in human and animal health. The mandate
1OIE is the French acronym for Office International des Epizooties. The organization changed its name to
Organisation Mondiale de la Santé Animale in 2014, but kept the acronym OIE.
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of those institutions is to oversee the preparedness and response to emerging infectious
diseases. Thus, these institutions set the regulations, policies and actions to prevent and
respond to zoonotic and animal emergent infectious diseases.
The Canadian Food Inspection Agency (CFIA) enforces the Health of Animals Act,
which establishes the mandate to protect the health of livestock animals in Canada against
foreign and domestic animal diseases (Department of Justice Canada, 2015). The CFIA
has collaborated with other federal and provincial institutions in mitigating and investigat-
ing high-profile outbreaks such as Bovine Spongiform Encephalopathy (BSE) outbreaks
in Alberta and the highly pathogenic avian influenza virus (HPAIV) outbreak in British
Columbia in 2014-2015. In 2017 the CFIA was investigating an outbreak of bovine tuber-
culosis in Southeastern Alberta and Southwestern Saskatchewan.
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Table 1.1: Notable events of emergent infectious human, zoonotic and animal diseases.
Year Disease Geographical location Hosts Reference
2016 Zika virus The Americas Humans Kindhauser et al. (2016)
2014-2016 Ebola haemorrhagic fever West Africa Humans Gire et al. (2014)
2014 Highly pathogenic avian influenza
(H5N2)
British Columbia, Canada Poultry birds Xu et al. (2016)
2012 Schmallenberg virus Germany Cattle Hoffmann et al. (2012)
2012 Middle-East respiratory syndrome
coronavirus (MERS-CoV)
The Middle East Humans, camels, bats Alagaili et al. (2014)
2009 Pandemic H1N1 influenza Worldwide Humans, pigs, birds Smith et al. (2009)
2003-2004 Pandemic H5N1 influenza Eastern Asia Poultry and humans Li et al. (2004)
2003 Severe acute respiratory syndrome
coronavirus (SARS-CoV)
Canada, China Humans Ksiazek et al. (2003)
2001 Foot-and-mouth disease United Kingdom Livestock Haydon et al. (2004)
1994 Hendra and Nipah virus Australia Horses, bats Selvey et al. (1995)
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Sharing information among animal health institutions is key during situations like the
aforementioned outbreaks. This rationale led to the origin of the Canadian Animal Health
Surveillance Network (CAHSN), which was created to monitor and respond to threats to an-
imal, human and environmental health effectively under a One World-One Health initiative
(Kloeze et al., 2010). This network approach has four fundamental components: laboratory
diagnostics, surveillance, an information and technology platform and governance (Kloeze
et al., 2010). Those components are the pillars of the specific goals of the CAHSN ini-
tiative, which include the creation of a national system to report animal disease threats as
early as possible, the establishment of a laboratory network including federal and provincial
laboratories for the rapid diagnosis of animal diseases that have high consequences, and the
development of a network to share information between federal and provincial institutions
including animal and human public health organizations (Kloeze et al., 2010).
Although initiatives like CAHSN are important efforts that address challenges for the
surveillance and response to foreign animal diseases, the surveillance and control of highly
contagious pathogens of animals are still difficult activities for animal health organizations.
This could be explained by the fact that the transmission and spread of highly contagious
pathogens is not stopped by artificial or natural boundaries. Those pathogens can cause
profound effects in the global trade of livestock and, by extension, they can cause a severe
impact to people who depend on livestock. The OIE and the FAO refer to those diseases as
transboundary diseases, and the FAO considers them emergencies (Food and Agriculture
Organization of the United Nations, 2016).
The OIE requires member countries to notify animal health authorities of the presence
of some diseases that have a high risk of transmission and a high potential impact on the
health of animals and the international trade of livestock. Thus, the OIE includes those
diseases in its list of notifiable terrestrial and aquatic animal diseases (World Organisation
For Animal Health, 2017a) 2. In Canada, the Health of Animals Act also requires that
2Before the resolutions adopted by the International Committee of the OIE during its 72nd General Session
in 2004 (World Organisation For Animal Health, 2004), there used to be two lists of notifiable diseases to
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these diseases be reported (Department of Justice Canada, 2015). Some of the diseases
in the OIE list are anthrax, bluetongue, BSE, bovine viral diarrhea, classical swine fever,
foot-and-mouth disease (FMD), highly pathogenic avian influenza, rinderpest 3, rabies, and
many others (World Organisation For Animal Health, 2017a). Many of those diseases are
considered transboundary diseases, and regulations are in place across the world to mini-
mize the likelihood that those diseases enter other countries. Many of the travel restrictions
and policies, such as the prohibition against bringing meat products to other countries are in
place to avoid those diseases. A disease from that list that is particularly important is foot-
and-mouth disease. It is one of the most contagious animal diseases and it is the largest
barrier to the international trade of animals and animal products. FMD is an extremely
contagious vesicular disease of cloven-hoofed animals that has severe consequences in the
international trade of livestock and animal welfare around the world. For decades, the
rinderpest virus was one of the biggest menaces to the health of cattle across Asia, Africa,
and Europe. Rinderpest was declared eradicated by the FAO and the OIE in 2011, and since
then, FMD is arguably the greatest threat to the international trade of livestock.
1.3 Foot-and-mouth disease virus
The foot-and-mouth disease is caused by the foot-and-mouth disease virus (FMDV),
which was the first pathogen characterized as an animal virus (Loeffler and Frosch, 1898;
Brown, 2003). It is thought that the first written reports of the disease date back to 1514
and were authored by the Italian monk Fracastorius (Jamal and Belsham, 2013). The im-
portance of FMD for animal health around world is reflected by its presence in the scientific
the OIE: List A and List B. List A was for those “transmissible diseases that have the potential for very
serious and rapid spread, irrespective of national borders, that are of serious socio-economic or public health
consequence and that are of major importance in the international trade of animals and animal products”
(World Organisation For Animal Health, 2017b). Foot and mouth disease belonged in List A under such
classification system. List B was for those “transmissible diseases that are considered to be of socio-economic
and/or public health importance within countries and that are significant in the international trade of animals
andanimal products” (World Organisation For Animal Health, 2018). Diseases such as anthrax, rabies, and
bovine tuberculosis belonged in List B
3There are only two viral diseases in the world that have been eradicated: smallpox and rinderpest.
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Figure 1.1: Cumulative sum of PubMed search results for the term "foot-and-mouth dis-
ease". A PubMed query was submitted with the following terms: foot-and-mouth
disease[Title/Abstract] NOT hand[Title]. That query yielded results where the
term and "foot-and-mouth disease" was in the Title or Abstract of publications indexed
in PubMed and that do not include the term "hand" in order to rule out results for the hand,
foot and mouth disease. The PubMed search was performed on February 8, 2017. Data of
number of publications per year were retrieved from PubMed’s "Results by Year" option.
The cumulative sum of publications over this time period was calculated using the R sta-
tistical computing language (R Core Team, 2016) and plotted with the ggplot2 package
(Wickham, 2009).
literature: a search of the term "foot-and-mouth disease" in Pubmed yielded 6,772 results,
which shows the relevance of this disease and its aetiological agent in the scientific litera-
ture since the year 1872 (Figure 1.1).
Understanding the genome of FMDV is key for studying the nature of its high viru-
lence. FMDV is a non-enveloped, icosahedral virus with a positive sense single-stranded
RNA genome of approximately 8.4 kilobases that belongs to the genus Aphthovirus in the
family Picornaviridae (Alexandersen et al., 2003). The FMDV genome is composed of one
open reading frame (ORF) that encodes a polyprotein that is cleaved by proteolysis into 12
structural and non-structural proteins (Alexandersen et al., 2003) (Figure 1.2, Figure 1.3).
The FMDV genome has a viral protein (VPg) at its 5’ end, and the long UTR at the 5’
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Figure 1.2: Annotated complete genome of FMDV strain O TAW 1997 (GenBank acces-
sion: AF308157). Annotations of mature peptides are in green below the annotation for the
polyprotein coding sequence (yellow).
Figure 1.3: Proteolysis of the FDMV polyprotein. The schematic was reproduced from the
ViralZone website of the Swiss Institute of Bionformatics (http://viralzone.expasy.
org/all_by_species/98.html).
end contains an internal ribosome entry site (IRES). The P1 region of the genome encodes
the structural polypeptides, and the P2 and P3 regions encode the nonstructural proteins
associated with replication, such as the 3D polymerase. In addition, the FMDV genome
encodes a N-terminal leader protease (L protease) and the 3C protease. Finally, the 3’ UTR
is important in negative strand synthesis (Alexandersen et al., 2003).
1.3.1 Economic impact and regulatory implications
According to the work by Knight-Jones and Rushton (2013), the economic impact of
FMD can be categorized in direct losses and indirect losses. Direct losses are due to re-
duced production and changes in the structure of herds, while indirect losses are caused by
the costs of FMD control, poor access to markets and limited use of improved production
technologies (Knight-Jones and Rushton, 2013). The economic impact of FMD has been
studied in simulations of the introduction of the disease to countries that have an FMD-
free status (Knight-Jones and Rushton, 2013; Whiting, 2003; Carpenter et al., 2011) and in
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reviews of the impact of the disease in small stakeholders (Knight-Jones et al., 2016).
Part of the economic impact of the disease comes from the notification of FMD to the
OIE that triggers many restrictions for the trade of livestock and animal products. These
restrictions represent important economic losses for those countries with FMD because
they cannot trade live animals or livestock products with FMD free countries. If regular
outbreaks occur, then only processed products can be exported to FMD free countries; if
FMD is effectively controlled with vaccination and outbreaks can be detected, then meat
without bones can be exported. Moreover, even if a country is free of FMD, it will have
trade restrictions imposed to it if it trades with countries with FMD (Knight-Jones and
Rushton, 2013).
Simulations of the economic impact of the introduction of FMD to the USA and Canada
have shown that the emergence of FMD would be deleterious for the economies of these
two countries that currently are free of FMD. For example, the cost of an outbreak of FMD
in Canada has been estimated to be between $8.3 and $45.9 billion (CAD) (Whiting, 2003),
and the cost of an outbreak in California was estimated to be between $2.3 and $69.0 billion
(USD) (Carpenter et al., 2011). In both cases the range of estimated costs also take into
consideration the number of days of delay in the detection of the disease.
Canadian livestock and meat export markets would be in severe risk if FMD enters the
country. In 2015 Canada exported 829,842 head of cattle, 5,768,198 head of hogs and
5,509 head of sheep to the United States of America, its largest export market (Agriculture
and Agri-Food Canada, 2016). Canada’s red meat industry exported $2.08 billion of beef
and veal meat in 2016, while it exported $3.47 billion of pork in the same year (Agriculture
and Agri-Food Canada, 2017). Considering the scale of those markets, steps must be taken
in order to ensure the protection of the health of Canada’s production animals and meat
products. Furthermore, the impact of FMD in the regions where the disease is endemic is
estimated at over 6.5 billion USD, which can be devastating to economically vulnerable
livestock keepers and shepherds in those regions (Knight-Jones et al., 2016).
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1.3.2 Clinical signs and symptoms
One of the factors that make FMD such an important threat to the international trade of
livestock is its impact on the quality of meat and milk of infected animals. The clinical signs
of FMD are the formation of vesicles and lesions in the hooves and inside and around the
mouth, including the tongue (Alexandersen et al., 2003). The resulting pain usually leads
to severe lameness which results in a decrease in meat and milk quality (Alexandersen
et al., 2003). Although FMD is typically not fatal in adult animals, it is easily transmitted
by aerosol and it may lead to myocarditis in young animals and to abortions in some fe-
males (Alexandersen et al., 2003). The clinical signs of FMD are very similar to multiple
other viral vesicular diseases of animals such as vesicular stomatitis virus (VSV) (fam-
ily Rhabdoviridae), vesicular exanthema of swine virus (VESV) (family Caliciviridae),
swine vesicular disease virus (SVDV) (family Picornaviridae) and senecavirus A (family
Picornaviridae). Clinical signs differ between species (Alexandersen et al., 2003), within
vaccinated cattle herds, and within some cattle breeds from areas in which FMD is endemic
and the disease may circulate undetected (Kitching, 2002). Therefore, FMD cannot be di-
agnosed on the basis of clinical signs alone and laboratory evidence of the demonstration of
the antigen or nucleic acid of the virus is required (World Organisation for Animal Health,
2012).
1.3.3 Host range
Another reason why FMD is such an important disease for the international trade of
livestock is that the FMDV has a very broad host range: it infects all cloven-hoofed mam-
mals (order Artiodactyla), including domestic livestock species like cattle (Bos taurus),
swine (Sus scrofa), sheep (Ovis aries), and goats (Capra aegagrus hircus), as well as over
70 wild species (Alexandersen and Mowat, 2005). Indeed, circulation of the virus between
wild and domestic species has been observed in multiple cases and there are many literature
reviews that mention documented cases of FMD in wild animals (Arzt et al., 2011; Thom-
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son et al., 2003; Alexandersen and Mowat, 2005; Pinto, 2004). Notably, the African buffalo
(Syncerus caffer) is an important reservoir host in Southern Africa, and some reports say
that this species can carry the virus for up to 5 years or more (Alexandersen et al., 2003;
Hedger et al., 1972). Thus, the African buffalo is known as a carrier of FMDV, and trans-
mission of FMDV from carrier African buffalo to cattle has been identified (Alexandersen
et al., 2003). Results from experimental studies have shown the susceptibility of wild ani-
mals to infection with FMDV as well as the potential for transmission to domestic species.
For example, Moniwa et al. (2012) reported that Canadian white deer (Odocoileus virgini-
anus) experimentally infected with FMDV were susceptible to the disease and transmitted
the virus to cattle in an experimental setting.
Infection has also been described in species that belong to other taxa besides the order
Artiodactyla, including elephants (order Proboscidea) (Hedger and Brooksby, 1976), bears
(Order: Carnivora) (Officer et al., 2014), and many other species including vampire bats
(Weaver et al., 2013). The literature review by Weaver et al. (2013) discusses in depth the
presence of FMDV in wild animals. The taxon with the most published reports of FMD is
the order Cetartiodactyla, although there were other 16 taxa represented (Figure 1.4).
Animals such as horses and carnivores are highly resistant to the virus, but can act as
mechanical vectors and can transfer the virus if they are contaminated with it (Alexander-
sen and Mowat, 2005). This is why the CFIA requires that horses imported into Canada
from countries with FMD are sprayed or sponged down with approved disinfectant such
as Virkon, citric acid or diluted vinegar (Canadian Food Inspection Agency, 2012). CFIA
regulations also stipulate that the hooves need to be cleaned and disinfected upon arrival.
Disinfection steps for the import of horses to Canada also include the accompanying equip-
ment and transport vehicles (Canadian Food Inspection Agency, 2012).
FMD is generally regarded as a disease that poses very little risk for human health,
although some anecdotal accounts of infections of FMDV in humans have been reported
in the literature. However, these accounts of symptoms do not meet Koch’s postulates to
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Figure 1.4: Number of publications per FMD host orders identified in the review by Weaver
et al. (2013). The hosts listed in that review were identified from many papers in the lit-
erature. A Python script developed in-house (https://github.com/ropolomx/OliVR/
blob/master/retrieve_taxonomy.py) was used to take the species names in Table 1 of
Weaver et al. (2013) and automate searches of the NCBI Taxonomy database to retrieve
genus, order, family and subfamily information.
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confirm infection with FMDV (Alexandersen and Mowat, 2005). For example, in 1873,
a British physician reported the symptoms of FMD in a female patient who had been in
contact with cows infected with the disease (Briscoe, 1872). The physician also reported
that he had observed milder clinical signs of the disease in three children who had drank
milk from cows with the disease.
Foot-and-mouth disease is often confused by the layperson with the hand, foot and
mouth disease which is caused by a coxsackievirus, a different member of the family Pi-
cornaviridae. Although humans are not hosts and do not play an important role in the
amplification of the virus, they do play a role in the passive transport of the virus from
infected animals or contaminated surfaces to susceptible animals.
1.3.4 Transmission
Besides its broad host range, another reason FMD is so difficult to control is its ease
of transmission by different physical, biological and environmental means. The virus is
often transmitted by direct contact via secretions and excretions from infected animals to
susceptible animals (World Organisation for Animal Health, 2012), and other means of
transmission like aerosol (Alexandersen and Donaldson, 2002; Mikkelsen et al., 2003) and
fomites (i.e. objects that can carry pathogens) (Alexandersen et al., 2003) also make the
virus hard to control. Moreover, animals that recover from FMDV infection can still excrete
large numbers of virus particles (Alexandersen et al., 2003).
1.3.5 Distribution and global status
FMDV is enzootic to many countries in Africa, Asia and South America (Knowles and
Samuel, 2003). Countries and regions that are currently free of the disease include Canada,
the United States, Mexico, Central America, Australia, New Zealand, and parts of South
America. The distribution of serotypes is roughly as follows: serotype A and O are found
in many locations around the world, including South America, Africa, the Middle East, and
Southern and Eastern Asia. Serotype Asia1 is found in Asia while serotypes SAT1, SAT2
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and SAT3 are located in Southern Africa. Serotype C had been historically found in Europe,
South America, East Africa, North Africa, and southern Asia (Knowles and Samuel, 2003).
However, the OIE/FAO Foot-and- Mouth Disease Reference Laboratory Network reported
in 2016 that serotype C has not been detected since 2004, and discussions were going to
be held to consider the evidence in support of its extinction (OIE/FAO Foot-and-Mouth
Disease Reference Laboratory Network, 2016).
The emergence of FMDV has been damaging to the economies of countries that had pre-
viously held an FMD-free status for decades. Notable examples of the emergence of FMD
include the outbreaks in the United Kingdom in the years 2001 and 2007, the outbreak in
Japan in the year 2000 (Sugiura et al., 2001), South Korea 2001 (Joo et al., 2002), and Tai-
wan in 1997 (Yang et al., 1999). Besides being one of the best documented, investigated,
and studied outbreaks of FMD in history, the 2001 outbreak in the United Kingdom is an
example of how devastating an FMD outbreak can be to a country’s economy and agricul-
tural sector. The cost of that outbreak was estimated to be 8 billion British pounds (Haydon
et al., 2004), and there were also psychosocial consequences such as the documented stress
experienced by British farmers due to the slaughter of over 6.5 million animals (Mort et al.,
2005). Moreover, the trade restrictions that were imposed on the UK represented a large
cost on that nation’s agricultural industry for years following the 2001 outbreak.
FMD has not been reported in Canada since an outbreak occurred in Saskatchewan
in 1952 (Sellers and Daggupaty, 1990), and the last time the disease was reported in the
United States of America was in 1929 (Carpenter et al., 2011). The threat of this disease
has lead many countries previously free of the disease to develop initiatives such as CAHSN
in which laboratory diagnostics play a fundamental role.
1.3.6 FMDV serotypes and topotypes
The early detection of known and emerging animal diseases is one of the primary goals
of the federal and provincial regulatory animal health agencies that are involved in the
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CAHSN initiative (Kloeze et al., 2010). In the case of many bacterial and viral pathogens,
the determination of the subtype or serotype of the pathogen in question is required to
characterize better the circulating strains. Serotypes are determined by antigenic variants
that result from variations in proteins in the viral surface, and the first report in the literature
of classification of bacterial serotypes was done by Rebecca Lancefield in 1933 (Lancefield,
1933). In the case of FMDV, the serotype of an FMDV strain is determined by the VP1
surface protein which is encoded by the 1D gene. There are currently seven serotypes of
FMDV: A, O, C, Asia 1 and SAT (Southern African Territories) 1, 2, and 3 (Alexandersen
et al., 2003; Domingo et al., 2003).
Being a single-stranded RNA (ssRNA) virus, FMDV has high genetic and antigenic
variation and it undergoes a rapid evolution, something that results in diversity that is ob-
served even within viruses of the same serotype (Domingo et al., 2003; Sobrino et al.,
1983). A key implication of the high antigenic diversity of FMDV is that protecting an-
imals by vaccinating against one serotype does not provide protection against any of the
other serotypes, and even between viruses of the same serotype (Alexandersen et al., 2003).
A molecular epidemiology analysis reported that the seven FMDV serotypes can be classi-
fied into distinct genetic lineages based on differences in the sequence of the 1D gene. The
variation between serotypes in this region ranges from 30% to 50% (Knowles and Samuel,
2003). Furthermore, the same study introduced the term topotype, which refers to the phy-
logenetic groups of strains of FMDV of the same serotype based on geography (Knowles
and Samuel, 2003). The importance of knowing the serotype and topotype is reflected by
the inclusion of these terms in the reports by the World Reference Laboratory for FMD on
new strains that are sequenced by that laboratory.
The patterns of sequence variation between FMDV genomes are complex, and FMDV
is one of most studied viruses in research to characterize and understand viral quasispecies
(Domingo et al., 1985, 1992, 2005). Sequence analysis techniques for the study of viral
quasispecies have been developed from work that was originally done on FMDV. Interest-
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ingly, one of the first applications of split decomposition phylogenetic analysis, which is
used to identify recombination and study reticular evolution, was in a study of foot-and-
mouth disease virus (Dopazo et al., 1993). Because of the considerable genetic variation
that is observed between FMDV genomes, there is no cross-protection between FMDV
serotypes and between some topotypes, the rapid and accurate identification of the serotype
of circulating strain is critical for the vaccine matching process with strains of the same
serotype as the field strain (Paton et al., 2005).
Due to the importance of FMD to international animal health authorities, each year the
FAO World Reference Laboratory and OIE Reference Laboratory for FMD at the Pirbright
Institute (Pirbright, Surrey, United Kingdom) publishes a report on the global status of the
disease. The World Reference Laboratory also publishes quarterly reports on the status
of new strains for which the 1D gene has been sequenced. Phylogenetic trees and vaccine
matching reports are included in such quarterly and annual reports which are available to the
public. Because of the importance of characterizing the serotype of FMDV field strains and
the rapid evolution and high genetic and antigenic variation of this virus the development of
new and improved methods for detection and serotyping of FMDV is paramount to ensure
successful monitoring of the disease should it ever enter countries that are currently free of
it.
1.3.7 Methods for detection and serotyping of FMDV
Detection of FMDV is a topic of great interest in the scientific literature: according
to a literature search in PubMed using the terms "foot-and-mouth disease virus detection"
showed that 593 articles containing those terms have been published from 1952 to 2017
(Figure 1.5).
According to the World Organisation for Animal Health (2012), FMDV should be iden-
tified by confirmation of the viral antigen or nucleic acid from epithelial tissue. In the same
document the following methods for the identification of FMDV are listed: virus isolation,
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Figure 1.5: Cumulative sum of PubMed search results of the term "foot-and-mouth dis-
ease virus detection". The PubMed search was performed on January 17, 2017. Data of
number of publications per year were retrieved from PubMed’s "Results by Year" option.
The cumulative sum of publications over this time period was calculated using the R sta-
tistical computing language (R Core Team, 2016) and plotted with the ggplot2 package
(Wickham, 2009).
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indirect sandwich ELISA, solid-phase competition ELISA (SPCE), liquid-phase blocking
ELISA (LPBE), virus neutralisation test, complement fixation, lateral flow device tests,
and nucleic acid detection methods such as end-point reverse-transcriptase PCR (RT-PCR)
and real-time RT-PCR. To understand the state of the art of methods for the detection and
serotyping of FMDV, a survey of those methods is presented.
1.3.7.1 Viral isolation
The gold standard of detection of FMDV is viral isolation in cell culture, for which
the use of epithelium samples is preferable (World Organisation for Animal Health, 2012).
The OIE recommends the use of primary bovine (calf) thyroid cells and primary pig, calf or
lamb kidney cells or other cell lines such as BHK-21 (baby hamster kidney) and IB-RS-2
(porcine kidney cell line) (World Organisation for Animal Health, 2012). The cell cultures
should be examined for cytopathic effect (CPE) for 48 hours. If no CPE is detected, the
cells should be frozen and thawed, used to inoculate fresh cultures and examined for CPE
for another 48 hours (World Organisation for Animal Health, 2012).
1.3.7.2 ELISA
The OIE’s preferred method for the detection of FMDV and the identification of the
serotype is the enzyme-linked immunosorbent assay Enzyme-linked immunosorbent assay
(ELISA) (World Organisation for Animal Health, 2012), and it is one of the most used
methods for the detection of foot-and-mouth disease virus and many other viral and bac-
terial pathogens. Equivalent or higher sensitivity of detection of FMDV than viral isola-
tion and complement fixation has been achieved with ELISA assays (Ma et al., 2011). The
ELISA method was first published in 1971 by Eva Engvall and Peter Perlmann (Engvall and
Perlmann, 1971). The assay has been described by Dr. Engvall as a simple technique that
made it easy for researchers to detect antibodies avoiding the use of radioactive isotopes
(Engvall, 2010). The advantages of ELISA are that it is a fast method, the existence of
highly automated ELISA protocols and that the results can be interpreted by a spectropho-
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tometric scanner. In a direct ELISA test, in which antigens are detected, known monoclonal
antibodies are placed in the walls of a microtitre plate and a diagnostic sample is added to
each well. If the antigen, and by extension the virus, is present, the antigen will bind to the
fixed antibody. To detect this reaction, secondary antibodies linked to an enzyme are added
and a complex of fixed antibody, virus and enzyme-linked antibody is formed. Then, the
substrate for the enzyme that is linked to the antibody is added and the reaction produces a
product that causes a visible colour change. The colour change can then be measured by a
spectrophotometric scanner.
In an indirect ELISA test, antibodies in a sample are detected. Instead of antibodies,
in an indirect ELISA it is antigens that are adsorbed onto the walls of the well of the mi-
crotitre plate. Then serum sample is added and if antibodies against the fixed antigen are
present, they will bind to the antigen. The way in which this reaction is detected is by
adding an enzyme-linked anti-HISG immunoglobin that will bind to antibodies that can be
used to detect expression of fusion proteins from bacterial, insect, and mammalian cells,
in particular the sequence His-His-His-His-His-His-Gly (6xHis-Gly epitope). In a similar
fashion to the direct ELISA, a sandwich of fixed antigen, antibody from the sample, and
enzyme-linked anti-HISG is formed and substrate is added which results in a visible colour
change if antibodies against the antigen are indeed present.
In the Manual of Diagnostic and Vaccines for Terrestrial Animals of the OIE it is clar-
ified that this refers to an indirect sandwich procedure like the one described above. In the
case of detection of FMDV, the wells of the microtitre plate are coated with rabbit antisera
against each of the seven serotypes of FMDV. Sample suspensions are added to each of
the wells of the plate as well as controls. Guinea pig antisera to each of the serotypes of
FMDV are added next, followed by rabbit anti-guinea-pig serum immunoglobin conjugated
to horseradish peroxidase. In this case, an absorbance reading greater than 0.1 above back-
ground indicates a positive reaction; the serotype of FMDV can also be identified. Values
close to 0.1 should be confirmed by retesting or by amplification of the antigen by tissue
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culture passage and testing the supernatant once a cytopathic effect has developed (World
Organisation for Animal Health, 2012).
Furthermore, the OIE recognizes ELISA tests to detect antibodies against the structural
proteins of the virus. These tests are serotype-specific, highly sensitive and able to detect
antibodies resulting from infection as well as vaccination. These tests are appropriate for
confirming previous or ongoing infection in non vaccinated animals as well as for moni-
toring the immunity conferred by vaccination in the field. These tests are considered by
the OIE as prescribed tests for international trade of livestock (World Organisation for An-
imal Health, 2012). Ma et al. (2011) reviewed over 100 studies of ELISA for detection of
FMDV and concluded that antibody-trapping and competitive ELISAs have high specificity
and RT-PCR (oligoprobing) ELISA has extra sensitivity. The limitations of ELISA are that
it does not have sufficient sensitivity and sensitivity and specificity, and that it takes hours
to obtain results (Yang et al., 2013).
1.3.7.3 Virus neutralization
Like the SPCE and the LPBE, the virus neutralization test is a prescribed test for the in-
ternational trade of livestock (World Organisation for Animal Health, 2012). Neutralization
is the reaction between antigen and antibodies in which the antibodies block the cytopathic
effect of the virus. This principle is used to detect the presence of antibodies against that
virus in a sample. If the sample contains antibodies against the virus, the virus will be neu-
tralized and it will prevent the virus from infecting cells. The virus can be titred using this
method and the TCID50 can be determined, which is the 50% tissue culture infective dose
(World Organisation for Animal Health, 2012). Besides being a method used for the detec-
tion of FMDV antibodies, the virus neutralization assay is used for the process of vaccine
matching.
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1.3.7.4 Lateral flow assays
Lateral flow assays are emergent technologies for the detection of antibodies of FMDV.
In a study on the development of lateral flow assays for the detection of FMD specific
monoclonal antibodies against serotypes A, O, and Asia1 were produced and used as the
capture monoclonal antibodies (Yang et al., 2013). Another multiplex lateral flow assay
targeting serotypes A, O, and Asia1 that featured three test lines for the simultaneous testing
of those three serotypes was also developed (Yang et al., 2015). That multiplex lateral flow
strip test was able to detect and differentiate 46/46 serotype O, 45/45 serotype A, and 17/17
serotype Asia1 samples. However, there were 5/8 serotype C samples that cross-reacted
with the serotype A test. Another lateral flow assay was used for detection of the viruses
of the seven serotypes and for the differentiation of serotypes A, O, C and Asia1 (Morioka
et al., 2015). That assay was able to detect samples representing all seven serotypes.
The lateral flow based immunological assays are relatively quick (less than 10 minutes),
cheap and user-friendly; however, these tests are less sensitive than molecular assays (ap-
proximately 80%) (Yang et al., 2013, 2015; Morioka et al., 2015; Ambagala et al., 2016).
1.3.7.5 Molecular biology methods
The creation of the polymerase chain reaction (PCR) (Saiki et al., 1988) has resulted in
the development of rapid, sensitive and specific laboratory methods that have been widely
adopted by regulatory animal health laboratories for the detection of animal pathogens like
FMDV. PCR requires the presence of a target, primers, polymerases such as Taq and dNTPs
and ions to improve the efficiency of the enzyme. Because FMDV is a positive ssRNA virus
and the thermostable Taq polymerase is a DNA polymerase, FMDV RNA is converted to
DNA with the help of a reverse-transcriptase enzyme. This kind of assays is therefore
known as reverse-transcriptase PCR (RT-PCR).
Traditionally, the amplified nucleic acids generated with PCR are visualized by agarose
gel electrophoresis. In this method, the nucleic acid with a negative charge is moved
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through an agarose gel matrix and ethidium bromide intercalates into the strands of DNA
and it fluoresces under ultraviolet light. Size markers are used to measure the size of the
amplified product.
This methodology is also known as end-point PCR, and its main challenge to the de-
tection of foot-and-mouth disease virus is the variation of the sequences of new viruses.
The rapid evolution of the FMDV makes it challenging to update the primers so that a high
coverage of PCR primers remains.
Early PCR methods for the differentiation of FMDV serotypes include the work per-
formed by Rodríguez et al. (1992) in which serotypes A, O and C were differentiated.
Another multiplex PCR assay was developed to differentiate the seven serotypes (Callens
and De Clercq, 1997). Constant refining and improvement of PCR methods for the detec-
tion of FMDV has been observed in the literature. The PCR procedure described by the
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals is performed at the OIE
and FAO World Reference Laboratory at The Pirbright Institute and was developed by Reid
et al. (2000).
The development of real time PCR has been a step forward in the molecular detection of
FMDV and many other viral pathogens of animals. The real time reverse transcription PCR
method referenced by the OIE involves the presence of a probe that generates a fluorescence
reaction when it hybridizes to the target. A Ct threshold value is then measured and reported
in real-time (hence the name). However, real-time PCR faces the same challenge of primer
sensitivity as with end-point PCR. Although it has been suggested that the sensitivity of
real time PCR can be higher than viral isolation (Pierce et al., 2010), many of the assays in
the literature are designed to yield an universal product or cannot be used to discriminate
between the seven serotypes. Also, some samples have not reacted with serotype-specific
primers in RT-PCR experiments (Reid et al., 2001). The methods listed above normally
require individual tests to be performed for each or a few serotypes.
Examples of other approaches for the detection of the nucleic acid of FMD are the
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isothermal methods which do not require thermocycling such as the loop-mediated isother-
mal amplification (LAMP) and nucleic acid sequence-based amplification (Longjam et al.,
2011). An insulated isothermal PCR (iiPCR) assay that targeted the FMDV 3D RNA poly-
merase gene, a highly conserved region of the FMDV genome, detected FMDV RNA in
vesicular fluid samples without nucleic acid extraction (Ambagala et al., 2016). The ad-
vantages of iiPCR, and in particular of the POCKIT instrument, are that it is compact and
potentially field deployable and the assay can be completed within one hour (Ambagala
et al., 2016).
1.3.7.6 Next generation sequencing
Next generation sequencing (NGS) technologies (Shendure and Ji, 2008) have enabled
the high throughput sequencing of many viruses, including FMDV. Sequencing FMDV
is important for monitoring global patterns of virus distributions, tracing sources of out-
breaks, and recognize early the emergence of new lineages, as well as antigenic prediction
and vaccine selection. Advances in NGS technologies have enabled researchers with the
possibility of sequencing the complete genome of this virus, which brings the advantage
that the full genome sequence data has increased resolution for analyzing and tracing the
spread of FMDV during outbreak situations. Another advantage of using NGS is that it
allows the study of population diversity beyond consensus sequences within samples (i.e.
viral quasispecies) (Freimanis et al., 2016). A limitation of NGS that has been noted in the
literature is it becomes difficult to identify recombination between different strains if the
samples contain parental and recombinant strains (Jamal and Belsham, 2018).
1.3.7.7 Microarrays
Microarrays occupy an interesting place in the history of pathogen detection methods
because they were some of the first technologies with the ability of performing multiple
molecular tests in a single reaction. Microarrays were developed in the 1990s as a method
for quantifying the expression levels of many genes in parallel, and the first microarray
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measured the expression of 45 Drosophila genes (Schena et al., 1995). Microarrays have
high throughput since many samples can be tested at the same time, and these technolo-
gies contain collections of oligonucleotides which can be probed with target molecules
(e.g. PCR products) to produce signals that can be quantified by a specialized instrument
(Miller and Tang, 2009). One of the most important advantages of microarrays over other
molecular methods such as PCR is that hundreds, thousands, or even tens of thousands of
oligonucleotide probes can be used to simultaneously test multiple samples. This makes
microarrays suitable for testing the presence of many pathogens simultaneously or multi-
ple subtypes of the same pathogen in parallel, thus saving the need for conducting a large
number of separate tests. The adoption of microarrays for the detection and subtyping of
pathogens is the result of the integration of innovations and advances in molecular biology,
biochemistry, robotics and bioinformatics (Miller and Tang, 2009).
Those innovations are presented in the literature review by Miller and Tang (2009), a
comprehensive survey of the application of microarrays to clinical microbiology. That re-
view presented the state of the art up to 2009 in detail, and discussed the technical advances
and diversity of microarray technologies and the various applications of these technologies
to laboratory diagnostics of microorganisms. Those applications include the detection and
subtyping of pathogens, the determination of antimicrobial resistance in bacteria, the pro-
filing of the expression of microbial genes, the profiling of the expression of host genes
during microbial infections and the determination of host genetic polymorphisms related to
the host immune response (Miller and Tang, 2009).
Two notable examples of the application of microarrays to clinical microbiology are
the first panviral microarray (Wang et al., 2002; Chen et al., 2011) and the first panmi-
crobial microarray (Palacios et al., 2007). The first panviral microarray was known as the
ViroChip, and it contained 70-mer oligonucleotides probes designed from highly conserved
regions within viral families (Wang et al., 2002). Only the sequences of 148 complete viral
genomes were used to design this chip, and although individual viruses were not explicitly
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represented on the microarray, they were still detected (Wang et al., 2002), and one of the
most important results obtained with the ViroChip was the discovery of the Severe Acute
Respiratorial Syndrome (SARS) coronavirus (Ksiazek et al., 2003).
The panmicrobial microarray was developed by Ian Lipkin’s laboratory and it was
known as the GreeneChipPm (Palacios et al., 2007). The GreeneChipPm contained 29,455
60-mer oligonucleotide probes for viruses, bacteria, fungi, and parasites and it was suc-
cessfully used to characterize a malarial infection of a patient who died from symptoms
that appeared to be haemorrhagic fever and that it was initially thought to be viral in origin
(Palacios et al., 2007). Many microarray assays have also been developed for the simultane-
ous detection and subtyping of animal viruses that share similar clinical signs. For example,
the simultaneous detection and subtyping avian influenza virus and the simultaneous detec-
tion and pathotyping of Newcastle disease virus was achieved with electronic microarray
assays (Lung et al., 2012). Another example of this kind of assay is that the detection and
differentiation of vesicular diseases of livestock including FMDV, VSV, SVDV and VESV
was achieved using a multiplex PCR and a glass slide microarray assay (Lung et al., 2011).
Another glass slide microarray achieved the identification to genus level of many viruses
that cause vesicles or vesicular-like lesions such as foot-and-mouth disease virus, vesicular
stomatitis virus, swine vesicular disease virus, vesicular exanthema of swine virus, bovine
herpesvirus 1, orf virus, pseudocowpox virus, bluetongue virus (bluetongue virus (BTV))
and bovine viral diarrhea virus (Bovine viral diarrhea virus (BVDV)) (Jack et al., 2009).
Another slide microarray that differentiated viruses that cause vesicular diseases was the
assay that discriminated between cDNA of FMDV, VSV and SVDV using padlock probes
(Banér et al., 2007). Other examples of microarrays for the differentiation of pathogens
include a glass slide microarray and an electronic microarray assay for the detection and
differentiation of the multiple pathogens in the Porcine Respiratory Disease Complex (Lung
et al., 2017), a microarray for the differentiation of lyssavirus species (Xi et al., 2012).
Microarray assays to differentiate viruses that infect the same species of animals can
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be of interest to veterinarians and farmers. One example is a multiplex PCR and elec-
tronic microarray to simultaneously detect eight viruses that infect cattle: vesicular stom-
atitis virus, bovine viral diarrhoea virus type 1 and type 2, bovine herpesvirus 1 (BHV-1),
BTV, malignant catarrhal fever virus (MCFV), rinderpest virus (RV) and parapox viruses
(Lung et al., 2016). Another multiplex PCR and an electronic microarray for the differen-
tiation of seven high consequence swine viruses which included: FMDV, swine vesicular
disease virus (SVDV), vesicular exanthema of swine virus (VESV), African swine fever
virus (ASFV), classical swine fever virus (CSFV), porcine respiratory and reproductive
syndrome virus (PRRSV), and porcine circovirus type 2 (PCV2) (Erickson et al., 2017).
Glass slide microarrays were once the most common types of microarrays for pathogen
detection assays. Some of their disadvantages are that multiple pieces of laboratory equip-
ment are typically required when working with glass slide microarray protocols. For ex-
ample, in Lung et al. (2011) slides were printed with probes that had been dried in using
a speed-vacuum and were resuspended in an epoxide spotting solution. The probes were
printed using a VersArray ChipWriter Pro printer with controlled humidity that was grad-
ually raised from 60% to ambient humidity conditions and the slides were kept in a desic-
cating chamber until they were used (Lung et al., 2011). Then slides were pre-hybridized,
then washed and dried in a slide centrifuge.
The automation of steps of the experimental workflow of microarrays allows for the
rapid and accurate identification and characterization of human and animal pathogens with
less human intervention. Highly automated microarray platforms such as the Nano-Chip
400 electronic microarray instrument (NC400; Nanogen Inc., San Diego, California, USA),
in which probe printing, sample addressing, reporting, washing and image acquisition are
programmed by the user and automatically performed by the instrument. RT-PCR and
data analysis are not integrated into the Nano-Chip400 instrument and must be performed
separately. In addition, the electrophoretic addressing of capture probes and hybridization
driven by electrophoresis (as opposed to passive hybridization in glass slide microarray)
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speed the process. The electrophoretically driven probe printing and sample addressing is
done via the biotin-streptavidin bond between the 5’end of the probes and the streptavidin-
coated hydrogel pads. If the probe hybridizes with the target amplicon, since the amplicon
has a tag sequence which binds to a fluorescent reporter probe, the fluorescence will remain
after several washing steps and will be quantified by a specialized instrument (Figure 1.6).
An important trend in the history of microarray technologies that was not captured in
the review by Miller and Tang (2009) is the introduction of fully automated arrays. The
development of lab-on-a chip technologies and innovations in engineering and microflu-
idics has allowed the creation of portable tests that can be applied bed-side and pen-side.
Important advances in microfluidics include the development of glass slide lab-on-a-chip
tests and the development of paper microfluidic devices (Martinez et al., 2008).
An example of full automation of array-based detection is the Rheonix platform in
which nucleic acid extraction, nucleic acid amplification and detection by reverse dot blot
microarray take place in a contained card with the aid of microfluidics (Spizz et al., 2012).
This technology has been applied to a range of diagnostic scenarios such as the detection
and differentiation of four sexually transmitted pathogens (Neisseria gonorrhoeae, Chlamy-
dia trachomatis, Treponema pallidum, and Trichomonas vaginalis), the detection and dif-
ferentiation of 20 clinically relevant human papillomavirus (Human papillomavirus (HPV))
types with cloned DNA, and the single nucleotide polymorphism genotyping of warfarin
sensitivity markers (Spizz et al., 2012). Another example of fully automated Rheonix ar-
rays is the simultaneous detection of Human immunodeficiency virus (HIV) antibodies and
nucleic acids in oral fluids (Chen et al., 2013), the detection of C. trachomatis, N. gonor-
rhoeae, T. vaginalis, and Mycobacterium genitalium (Yasmin et al., 2016). More recently,
a reverse-transcription loop-mediated isothermal amplification was coupled with automated
reverse dot blot analysis for the detection of the Zika virus (Sabalza et al., 2018).
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Figure 1.6: Schematic of the NC400 electronic microarray probe-target hybridization. The
cartoon was reproduced from Ortega Polo et al. (2013)
.
1.4 Objectives
This thesis presents work that was developed during the transition of molecular methods
and next generation sequencing being more widely adopted in the diagnostic laboratories.
The objectives of this thesis are:
1. To design, evaluate in silico and develop an RT-PCR and electronic microarray assay
for the simultaneous detection and serotyping of FMDV (chapter 2).
2. To study the coverage and specificity of the microarray probes in silico detecting new
strains (chapter 3).
3. To compare different in silico methods for the characterization of FMDV genomes
and NGS data (chapter 3).
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Chapter 2
Design and development of an electronic
microarray assay for the simultaneous
detection and serotyping of FMDV
Note to the reader: Some methods and results reported in this chapter were already pre-
sented in a poster at the 32nd Annual Meeting of the American Society for Virology (Or-
tega Polo et al., 2013) and published recently in the peer-reviewed article by Erickson et al.
(2017). In that article, a multiplex RT-PCR and electronic microarray assay was designed
to differentiate seven viruses affecting swine, while in the work presented in this chapter
the focus is on the simultaneous detection and serotyping of foot-and-mouth disease virus.
2.1 Abstract
The foot-and-mouth disease virus (FMDV) is a highly contagious pathogen of cloven-
hoofed animals, and one of the biggest hurdles for the international trade of livestock. The
rapid and accurate detection of this virus is instrumental in preserving the livestock markets
of countries that are currently free of the virus. In this study, an electronic microarray assay
was developed for the simultaneous detection and serotyping of FMDV. The coverage and
specificity of the assay for the detection and characterization of FMDV was evaluated in
silico. The assay was able to detect and correctly type 19 synthetic constructs and 23 viral
RNA samples in an initial laboratory validation. Further validation with additional samples,
determination of the limit of detection, and transferring the assay to a portable platform
are suggestions for improving this assay towards its adoption into veterinary diagnostics
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programs in Canada.
2.2 Introduction
The detection of foot-and-mouth disease virus (FMDV) is a very important issue for an-
imal health authorities and regulatory agencies around the world. Considered a reportable
disease by the World Organization for Animal Health (OIE), the foot-and-mouth disease
FMD is extremely contagious and has important consequences for the international trade
of livestock. Because of the importance of FMDV, characterization of FMDV serotypes
routinely applied as part of laboratory diagnostics of FMD. Several molecular and sero-
logical assays have been developed for the detection and serotyping. Although molecular
assays such as PCR or real-time PCR have higher sensitivity than serological methods for
virus detection, the genetic diversity of FMDV is very high, and molecular assays have to
be monitored and updated regularly to ensure adequate coverage. Microarrays can include
multiple probes which makes them suitable for subtyping highly variable and fast-evolving
viruses like FMDV due to the ability of include probes that in combination provide higher
coverage than individual oligonucleotides because probes that detect certain strains may
not detect other strains. This property of microarrays is useful when probes that worked in
the past with certain strains may not be as effective when tested with new field strains.
An example of the application of microarrays to the differentiation of viral subtypes was
the development of a glass slide microarray that discriminated between the seven serotypes
of FMDV (Baxi et al., 2006). In contrast to the labour-intensive and time-consuming glass
slide microarray technologies, electronic microarrays are highly automated and allow the
implementation of multiplexing and high-throughput testing of multiple pathogens and sub-
types of pathogens. Moreover, electronic microarray assays have been successfully used in
previous studies for the differentiation and subtyping of animal viruses (Gall et al., 2009;
Lung et al., 2011, 2012, 2016; Erickson et al., 2017). In this study, the design, development,
and initial laboratory validation of an electronic microarray for the simultaneous detection
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and serotyping of FMDV are presented. This is the first report of an electronic microarray
assay for the simultaneous detection and serotyping of FMDV.
2.3 Materials and methods
2.3.1 In silico assay design and evaluation
2.3.1.1 Reverse-Transcriptase PCR primers
The FMDV serotyping electronic microarray assay was designed to complement
the multiplex Swine High Consequence (Swine High Consequence (SHC)) reverse-
transcriptase PCR (RT-PCR) and microarray assay described in Erickson et al. (2017)
which targeted the following viruses: swine vesicular disease virus (SVDV), classical swine
fever virus (CSFV), vesicular exanthema of swine virus (VESV), African swine fever virus
(ASFV), porcine circovirus (PCoV), and porcine respiratory and reproductive syndrome
virus (PRRSV) (Table 2.1). In order to maximize the coverage of the genetically variable
FMDV, the multiplex RT-PCR primers were designed to cover the high number of sin-
gle nucleotide polymorphisms (SNPs) found across the FMDV strains. A pool of forward
primers consisting of a set of 9 primers targeting the same binding region of the highly
conserved 2A gene was used in this study, instead of a forward primer with multiple de-
generacies to avoid the unnecessary dilution of the primers and to minimize the number
of primers used in the RT-PCR. The sequence of the reverse FMDV primer contained two
degenerate bases (Table 2.1).
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Table 2.1: Primers of the Swine High Consequence multiplex RT-PCR
Primer name Virus Genomic region Amplicon size (bp) Sequence (5’-3’) Reference
VP3com980(1)
FMDV 1C-1D-2A-2B 971
GCTGATTACGCGTACAC Erickson et al. (2017)
VP3com980(2) GCTGACTACGCGTACAC Erickson et al. (2017)
VP3com980(3) GCGGATTACGCCTACAC Erickson et al. (2017)
VP3com980(4) GCGGATTACGCGTACAC Erickson et al. (2017)
VP3com980(5) GCTGACTATGCTTACAC Erickson et al. (2017)
VP3com980(6) AGTGACTTCTCCTACAC Erickson et al. (2017)
VP3com980(7) GCAGATTACGCGTATAC Erickson et al. (2017)
VP3com980(8) GCAGACTTTGCATACAC Erickson et al. (2017)
VP3com980(9) GCAGACTTTGCCTAYAC Erickson et al. (2017)
FMDV 2B Rev 4026-S-Deg2* GCGGACACCARCCGGTTRAAGTC Erickson et al. (2017)
SVDVCV-3C-17a-F-(5875bp)
SVDV 3C/3D 791
CAGCGGCACTCCTCAGACACTAC Lung et al. (2011)
SVDVCV-3D-3a-R-(6642bp)* GAGTTTCAGGCACGTAAACCACAC Lung et al. (2011)
KBH12-5 E1 Ext FWD
CSFV E1/E2 671
AGRCCAGACTGGTGGCCNTAYGA Paton et al. (2000)
KBH12-6 E2 Ext REV* TTYACCACTTCTGTTCTCA Paton et al. (2000)
King Long - Fwd Primer
ASFV VP72 537
ATAGGATTAAAACCTACCTGGAACATCTCCG King et al. (2003)
King Long - Rev Primer* GGTACTGTAACGCAGCACAGCTGAACCGTTCTG King et al. (2003)
VESVSM-2-F
VESV Polymerase 649
CGACTCGATGGACCTGTTCACATACG Lung et al. (2011)
VESVSM-5-R* CGTAGAGGTCGGTTAGGTCCTTTCTG Lung et al. (2011)
CircoV-1222F
PCV2 Capsid 534
GTAATCAATAGTGGAATCTAGGAC Lung et al. (2017)
CircoV-1760R TTCGTTTTCAGATATGACGTATC Lung et al. (2017)
PRRSV-mtrx-F
PRRSV Matrix 379
AAGGTAAGTCGCGGCCGAC Lung et al. (2017)
PRRSV-mtrx-R TGCCRCCCAACACGAGGC Lung et al. (2017)
*Reverse primers contain a complimentary tag sequence (mutseq; 5’-GCAGTATATCGCTTGACA-3’) for the LNA reporter probe at the 5’ end (Lung et al., 2012).
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Table 2.2: Concentration and volumes of the primers of the Swine High Consequence
seven-plex RT-PCR
Virus Primer Initial concentration (µM) Volume (µL) Final concentration (µM)
FMDV FMDV Forward primer pool 200 0.250 1.250
FMDV mutseq FMDV 2B Rev 4026-S deg 200 0.250 1.250
SVDV SVDV CV-3C-17a-F 200 0.125 0.625
SVDV SVDV CV-3D-3a-R 200 0.125 0.625
CSFV KBH 12-5 E1 Ext FWD 200 0.250 1.250
CSFV mutseq KBH 12-6 E2 Ext REV 200 0.250 1.250
VESV VESV SM-2-F 200 0.125 0.625
VESV mutseq VESV SM-5-R 200 0.125 0.625
ASFV ASFV-K F1 200 0.125 0.625
ASFV mutseq ASFV-K R 200 0.125 0.625
PCV CircoV 1222F 200 0.250 1.250
PCV mutseq CircoV 1760 R 200 0.250 1.250
PRRSV PRRSV-mtrx-F 200 0.125 0.625
PRRSV mutseq PRRSV-mtrx-R 200 0.125 0.625
Total 2.500 12.500
2.3.1.2 In silico evaluation of FMDV primer coverage
The coverage of the FMDV primers was assessed in silico by mapping the se-
quences of the primers to a set of 288 FMDV whole genome sequences that were
downloaded from GenBank on December 2013 representing all seven FMDV serotypes.
The primer mapping process was started by performing a multiple sequence align-
ment of the 288 complete genome sequences with MAFFT v7.215 (Katoh and Stand-
ley, 2013) using the --adjustdirection parameter and applying the G-INS-i strat-
egy. The sequences of the forward and reverse primers were added to the alignment
using the --addfragments option and the --adjustdirection parameter of MAFFT.
Once the primers were mapped to the multiple sequence alignment, a Python script devel-
oped in-house (extract_oligo_blocks.py; https://github.com/ropolomx/OliVR/blob/
master/extract_oligo_blocks.py) was used to find the blocks of the multiple sequence
alignment where the primer sequences were located.
Then, the script compared each position in the sequences of the primers versus each
position in the sequences of the strains and a binary score was computed by assigning a
value of 1 to matching bases and a value of 0 to mismatches. The script then calculated
the number of mismatches as the Hamming distance (Hamming, 1950) by calculating the
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sum of those positions where the bases of the primer and target are identical (i.e. had a
score of 1), and then subtracting that result from the length of the primer. After running
the script, the percentage of coverage of each primer was calculated as the number of hits
against the sequence database with 0, 1, 2 or 3 mismatches divided by 288 and multiplied by
100. The binarized SNPs of primers versus targets were plotted using the ggplot2 package
(Wickham, 2009) in the R statistical computing language.
2.3.1.3 In silico evaluation of FMDV primer specificity
For the purposes of this in silico evaluation, the term “virus-specific” refers to the set
of primer pairs that were designed for detecting each of the seven viruses of the SHC as-
say. The term “non-specific” refers to the other combinations of primer pairs of the SHC
assay. For example, a non-specific pair would be the forward FMDV primer and the reverse
classical swine fever virus (CSFV) primer.
The primers of the SHC assay were tested using different in silico methods against
genetically related viruses such as other members of the genus Aphthovirus and the fam-
ily Picornaviridae. The Basic Local Alignment Search Tool (BLAST) (Altschul et al.,
1997), the electronic PCR (e-PCR) and reverse electronic PCR (re-PCR) tools developed
by the National Center for Biotechnology Information (NCBI) (Schuler, 1997; Rotmistro-
vsky et al., 2004) were used to to identify potential cross-reactivities of the primers. A
multi-FASTA file with the SHC multiplex RT-PCR primer sequences was manipulated with
a Python script developed in-house (multiplex_interactions.py; https://github.
com/ropolomx/OliVR/blob/master/multiplex_interactions.py) to generate a ta-
ble with all the unique primer pairs that target viruses other than the viruses for which
the primers were originally designed. That table was the input for the e-PCR program
to evaluate the primers in silico versus all the sequences in the family Picornaviridae
that are not FMDV. A total of 81,546 non-FMDV Picornaviridae sequences were down-
loaded from NCBI with a Perl script originally developed by NCBI in which the following
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Entrez query was used: txid12058[Organism:exp] NOT txid12110[Organism:exp]
AND 100:11500[Sequence Length]. Identical sequences were collapsed using cdhit
v4.6 (Li and Godzik, 2006) using a sequence identity threshold of 100% which resulted in
61,995 unique sequences.
The unique non-FMDV Picornaviridae sequences were evaluated in silico with the SHC
RT-PCR primers using e-PCR. The tests were performed with 1, 2, 3, 4, 5 and 6 mismatches.
The specificity of the FMDV primers against host genomes was evaluated with in silico
simulations of PCR under reaction conditions. Those PCR simulations were performed
with the ThermoBLAST tool to predict possible hybridizations based on thermodynamic
models and not sequence complementarity alone (SantaLucia, 2007).
2.3.1.4 In silico evaluation of probe coverage
Pan-FMDV and serotype-specific probes were adopted from (Baxi et al., 2006) and
(Lung et al., 2011). A non-specific binding probe (NSBP) was included in all the experi-
ments as a negative control. This oligonucleotide has been used in previous electronic mi-
croarray studies (Lung et al., 2012, 2015, 2016; Erickson et al., 2017) and it was designed
from Thermotoga maritima sequences (Hindson et al., 2008). The evaluation methods of
coverage for both pan-FMDV and serotype-specific probes is presented below.
Pan-FMDV probes The pan-FMDV probes were designed as positive controls to detect
FMDV strains independently of their serotype and were designed to target a highly con-
served region spanning the 2A and the 2B regions of the FMDV genome. A set of 335
sequences representing all 7 serotypes which contain that highly conserved region used to
evaluate the coverage of the pan-FMDV probes (Table 2.3) were downloaded from NCBI
in 2012. This database is a subset of the database of complete genomes used for the evalua-
tion of primers in subsubsection 2.3.1.2. Probes were searches with BLAST and an identity
threshold of 80% and a query coverage of 75% were used to determine matches of the
probes vs. sequenced in the database.
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Table 2.3: Number of sequences in the 335 FDMV sequence database with pan-FMDV
probe region.
Serotype Number of sequences
A 85
O 150
C 31
Asia1 40
SAT1 11
SAT2 9
SAT3 9
Serotype-specific probes A set of 2,888 FMDV sequences was used for the evaluation
of the coverage and the specificity of the serotyping probes. Briefly, a set of accession num-
bers were retrieved in 2012 (n= 1,199) from the FMDV accession number databases main-
tained by the World Reference Laboratory for FMDV at The Pirbright Institute (Pirbright,
Surrey, United Kingdom) (http://www.wrlfmd.org/fmdv_seqs/fmdv_seq.htm). The
accession numbers were submitted to a GenBank search by means of a Batch Entrez query
(http://www.ncbi.nlm.nih.gov/sites/batchentrez) and the matching records were
downloaded from GenBank (Benson et al., 2009) in FASTA format. The sequences were
added to a database previously curated by the CFIA Lethbridge Laboratory (n=1,689). Se-
quences of other FMDV genomic regions such as 3D (polymerase) or L (protease) and
sequences that were less than 200 nucleotides were removed from the database before cal-
culating the 2,888 sequences. Each one of the seven serotype-specific sequences files were
aligned independently against a prototype sequence using the GlobalRef function of the
Clone Manager 9.0 suite (Sci-Ed, Cary, North Carolina, USA). Those prototype sequences
were identified from the public list of prototypes strains of the FMD World Reference
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Laboratory (http://www.wrlfmd.org/fmd_genotyping/prototypes.htm) (Table 2.4).
Then, to evaluate the in silico coverage of probes, the multiple sequence alignments were
manually trimmed to 1.2 Kb using Bio-Edit v.7.1.3.0 (Hall, 1999). The 1.2 Kb region con-
tains the 1C, 1D, 2A and 2B genes (Lung et al., 2011) and includes the 971 bp PCR product
used in the present study.
Queries of the probe sequences against each of the trimmed serotype databases
were submitted in local blastn searches (BLAST version 2.0) (Altschul et al., 1997)
through the graphic user interface of Bio-Edit v.7.1.3.0 (Hall, 1999). The se-
quences of degenerate probes were expanded using a Perl script developed at the
CFIA Lethbridge Laboratory (Beeston, A., https://gist.github.com/ropolomx/
19220e9bd6e20088115c39ba0d3283b0). After the degenerate sequences were expanded,
all probe sequences were evaluated against the sequence databases in local BLAST
searches. Default Bio-Edit BLAST settings were applied. The BLAST tabular outputs
were analyzed, and the probes that met the following stringent criteria were considered as
matches and were selected for further testing. In this case, percent query coverage was not
considered as a criterion due to the relatively short size of some of the oligonucleotides,
and thus criteria based on the number of mismatches was used to evaluate the coverage of
those probes.
• the probe-strain alignment was complete (100% of the probe length) with 0, 1 or 2
mismatches;
• the length of the probe-strain alignment was the probe length minus 1 base with 0 or
1 mismatches;
• the length of the probe-strain alignment was the probe length minus two bases with 0
mismatches.
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Table 2.4: Prototype reference FMDV strains used in this study for guiding multiple se-
quence alignments
Serotype Strain GenBank Accession
A A24 Cruzeiro AY593768
O O1 BFS/1860 AY593815
C C Wald 32 AY593810
Asia1 Asia1 Pak 1/54 AY593795
SAT1 SAT1 BEC 30 AY593838
SAT2 SAT2 RHO AY593847
SAT3 SAT3 BEC 1/65 AY593853
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Table 2.5: Probes used in the NanoChip400 electronic microarray experiments.Size is rep-
resented as the number of nucleotides (nt). The oligonucleotide capture probes were bi-
otinylated in the 5’ end and addressed to the streptavidin-coated pads in NanoChip 400
cartridges and tested with synthetic constructs or viral RNA. The following characters rep-
resent IUPAC codes of degenerate bases: Y (C, T), B (C, T, G), M (A, C), D (A, G, T),
R(A,G), S (C,G), W (A, T), and N (A, C, T, G)
Serotype Probe Sequence (5’-3’) Size (nt)
Pan-FMDV
FMD Common A (2A-
1)
AAGTTGGCNGGAGACGTBGAGTCCAACCC 29
FMD Common B (FV-
SAT2-235)
AACTTYGACCTGTTAAAGTTGGCBGGAGACGTTGAGTC 38
FMD Common C (FV-
SAT1-227)
AACTTCGACCTGTTAAAGTTGGCYGGAGACGTTGAGTCCAACCCT 45
FMD Common D
(FMDCom2A-3)
GAGTCCAACCCTGGGCCYTTCTTCTTC 27
FMD Common E
(2AREV3915Probe(deg))
GAGAYGTBGAGTCCAACCCTGGGCCYTT 28
FV-COM-081 ATTTTGACCTGCTCAAGTTGGCCGGAGACGTTGAGTCCAA 45
Com81mod AYTTYGACCTGYTMAAGTTGGCNGGAGACGTTGA 40
FV-SAT1-226 AACTTCGACCTGTTAAAGTTGGCCGGAGACGTTGAGTCCAACCCT 45
FV-SAT2-237 GACCTGTTAAAGTTGGCBGGAGACGTTGAGTCYAACCCTG 40
FV-SAT2-
238(237deg)
GACCTGTTAAAGTTGGCCGGAGACGTTGAGTCCAACCCTG 40
FMDCom237deg2 GACCTGYTVAAGTTGGCNGGAGACGTBGAGTCCAACCCTG 40
FMDCom2A–2 GACCTGYTVAAGTTGGCNGGAGACGTBGAGTC 32
A
A-T-23 GTGCGCATGAAACGGGCCGA 20
A-T-50 deg GARAACTACGGYGGTGAGACACAA 24
A-t-009 CTTCTCGTGCGCATGAAACG 20
A-T-27 AACGACACTCTGGTCGTGTCGGTTAGCGCCGGCAAGGA 38
FMD-A-137deg GTCGTCTCAAGACAGACACAAACAGAAGATCATTGC 36
FMD-A-137 GTCGTCTCAAGACAGACACAAACAGAAGATCATTGC 36
FV-A-119(008deg) TCCTGCTTCWTTYAACTACGGTGCAATCAAGGCCV 35
FMD A6 CACGARCTYCTCGTGCGYATGAA 23
FV-A-008 TCCTGCTTCATTTAACTACGGTGCAATCAAGGCCG 35
FV-A-135 GCACACCGACGTTACTTTCATAATGGACAGATTTGT 36
A-T-1deg GTCATTGACCTCATGCAAACCCACCARCAC 30
FV-A-127 CTTCTCAGATCTGGAAATTGTTGTGCGGCATGACG 35
O FV-O-148mod1 CAARTTAAYRTDTTGGACCTSATGCA 26
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Table 2.5: Probes used in the NanoChip400 electronic microarray experiments (continued).
Serotype Probe Sequence (5’-3’) Size (nt)
O
O-T-16 ATGGGTCTGCTTGTTTCAAAT 21
O-T-8deg CCGGTYGACGCCCGMACCCA 20
FV-O-014 CAATGTGAGAGGTGACCTGCAAGTATTGGCCCAAA 35
FV-O-015 TACTACTTCGCAGATCTAGAAGTGGCAGTGAAACA 35
FV-O-165 AACTGCTTTACCGCATGAAGAGGGCCGAAACATAC 35
O-304-323 CAAGTGTTGGCCCAGAAGGCGGC 23
O(Cody) GGTGCCATCAAAGCCAC 17
FV-O-154 ACACGGACATTGCGTTCATATTGGACAGGTTCGTG 35
FV-O-155 AGGCAACTCGTGTTACTGAACTACTCTACAGAATGAAG 38
FV-O-166 ACCAATGTGAGAGGTGACCTGCAAGTATTGGCTCA 35
FV-O-167 TACTTCGCAGACCTAGAAGTGGCAGTGAAACACGA 35
FV-O-169 GACACAAACAAAAGATTGTGGCGCCTGTGAAACAG 35
FV-O-178 CGGACGTTGCGTTCATATTGGACAGGTTCGTGAAAGT 37
O-T-14deg TTRGCGACCGTCTACAACGG 20
O-T-20deg ACACAGRTCCAGAGGCGCCA 20
O-T-31deg TGGTCGTRCTGGCTAGYGCTGG 22
FV-O-016 AATTAATGTGTTGGACCTGATGCAAACCCCTGCAC 35
O-T-24deg GAGATAGCAGTAAARCACGAGGGAGA 26
C
C24 TGAACTCTATTGTCCTAGGCCGATTCTTCCGATTC 35
FMD C18 TGGAAATAGCRGTGACCCACAC 22
C-L-002 CGATTCTTCCGATTCAGCCAC 21
FV-C-183 WGAACTCTATTGYCCTAGGCCGATTCTTCCGATTC 35
FV-C-192 TTGGTGCAGTTAAAGCAGAAACAGTCACTGAGCTG 35
FV-C-195 AACACACACTGGACGTGATGCAGGTACACAAAGAC 35
FMD VP1 643-662 CTCACATGGGTGCCCAACGG 20
FMD VP1 481-497 GCCTTCGTTCTTGACCG 17
Asia1
ASIA208mod2 CTTGACACCACYCAVGACCGCCG 23
ASIA-L011 ACGGYGCYGTRAAGGCYGA 19
FV-Asia-206 CGCTGTAAAGGCTGACAACATAACTGAGCTTTTGATCCGCATGAA 45
FV-Asia-040 AGGTCAAACTTCACAAAGTTGGTGGACACCATCAA 35
FV-Asia-203(034deg) TTYTCAGACCTGGARRTTGCGCTTGTYCACACAGG 35
FV-Asia-204(036deg) AARGAYTTTGAGTTTCGCYTRCWAGTKGAYGCACG 35
SAT1
SAT1-9 GTGGGCGACAAYCCVGTCGTCTTCTC 26
S1-L-002 STYCTSACRCACTACGACCA 20
SAT1-210mod2 TACAAYGGTGACTGYAAGTACAARCCCRCTGGC 33
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Table 2.5: Probes used in the NanoChip400 electronic microarray experiments (continued).
Serotype Probe Sequence (5’-3’) Size (nt)
SAT1
SAT1 VP1-2 GARGTBGACGTRTACGTSAGGATGAA 26
FV-SAT1-212 GGTGACTGCAAGTACAARCCCACTGGCA 28
SAT1215mod3 GATWTACACASAGGCAGARGTGGACGTGTACSTGAGGATGAA 42
FV-SAT1-267 TACAAAGTGGCCCTGACCAAACCTGCCAAACAATT 35
FV-SAT1-268 GATCACCAAGCCTGTCAAACAACTGTGTAATTTCG 35
SAT2
SAT2-T-31 CCAGTCGACGTTTACTACCGGAT 23
SAT2-T-23deg GGCGTCGAGAAACAAYTGTG 20
FMD S2-L-006 CTBCCNTCHACCTTCAAATTYGG 23
FV-SAT2-261 TTTGCTGTGGACCTCTTGGACACTAAGGACAAAAC 35
SAT2-T-13deg GGCGACAACCCMATGGTKTTC 21
SAT2-547-569 GACCTCATGGACACMAAGGAGAA 23
SAT2-604-623 TACTACTTCTGTGACCTGGA 20
SAT2-T-9deg GACAGATTCGACGCGCCYAT 20
FV-SAT2-255 GACAACCCAATGGTGTTTTCACACAACAACGTCAC 35
FV-SAT2-265 GGTGAGTGTGTTTACAAGAAAACTCCCACCGCCAT 35
Sat2-230 ACMTACTATTTYTGTGACCTGGAAATYRCVTGCCT 35
FV-SAT2-068 ACCTACTATTTCTGTGACCTGGAAATTGCCTGCCT 35
FV-SAT2-064 GATTCACCCATGTTCTGACAAATAGAACCGCGTTC 35
SAT3
SAT3-9 CCCACRACDTTCAACTTCGG 20
SAT3-8 TGGGTDCCCAACGGDTGCCC 20
S3-L-001 ACACGAAGGAACACACRYTG 20
FV-Sat3-242 CACACCAACGTGGAGTTTCTGCTGGACAGATTCACA 36
FV-Sat3-071 TACAAGACACCACTGGTCAAACCTGACAAGCAGAT 35
FVSat3-244 CCCACGACATTCAACTTCGGAAGATTGTTGTGTGAA 36
Negative control NSBP CAAAGTGGGAGACGTCGTTG 20
2.3.1.5 In silico evaluation of probe specificity
To assess the specificity of the serotyping probes in silico for the detection of each
serotype, probes of each serotype were queried in local BLAST and re-PCR searches
against all the sequences of the other serotypes using the criteria mentioned above. For
example, the serotype A probes were queried against all the FMDV sequences that were
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not serotype A.
2.3.2 Optimization of the assay with synthetic constructs
2.3.2.1 Synthetic constructs
Synthetic plasmid DNA constructs containing partial sequences of the FMDV amplicon
were used for screening FMDV detection and serotyping probes at the Lethbridge Labora-
tory of the National Centres for Animal Disease (CFIA). The synthetic constructs were
designed by other personnel at that laboratory and more details of the design can be found
in Appendix A. Plasmid vectors were cloned and propagated in Escherichia coli DH10B
electrocompetent cells. A volume of 1 µL of a 1/100 dilution of of each synthetic construct
were added to 20 µL of E. coli DH10B cells. The cells were transferred to 1 mm electropo-
ration cuvettes and electroporation was applied using a Gene Pulse X-cell system (Bio-Rad,
Mississauga, Ontario) with the following conditions: voltage of 1800 V, capacitance of 25
µF, and resistance of 200 Ω. After electroporation, a volume of 480 µL of Super Optimal
Catabolite (SOC) medium was added to the cuvettes. The mixtures of cells and medium
were transferred to the original E. coli cultures and incubated for 1 hour at 37◦C. A volume
of 250 µL of each transformed cell aliquot were plated on solid LB agar (Miller) medium
with ampicillin and plates were incubated overnight. Plates were removed from the 37◦C
oven, sealed with parafilm and stored at 4◦C overnight. Test tubes with LB broth medium
with ampicillin were inoculated by picking colonies with a sterilized pipette tip grabbed
with a sterilized pair of tweezers. The inoculated culture tubes were incubated overnight
at 37◦C. Tubes were visually inspected for turbidity and glycerol stocks were prepared by
adding 500 µL of 60%(w/w) glycerol and 500 µL of the culture grown on LB broth with
ampicillin. Glycerol stocks were stored at -80◦C. A volume of 1.5 µL of overnight E. coli
culture was transferred into a QIAcube microcentrifuge tube (QIAgen, Toronto, Ontario)
by transferring 2 aliquots of 750 µL each. Those tubes were centrifuged for 3 minutes at
13,000 rpm and the supernatant was discarded. The rest of the LB broth overnight culture
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was added to the QIAcube microcentrifuge tubes (approximately 700 to 740µL). The tubes
were centrifuged again for 3 minutes at 13,000 rpm and the supernatant was discarded. The
pellets were temporarily stored at 4◦C. Plasmid DNA was extracted from the pellets by us-
ing the QIAprep Miniprep 1.5 mL LB culture without Buffer PB protocol using a QIAcube
instrument (QIAgen, Toronto, Ontario). After the plasmids were purified and eluted, their
concentrations were measured in triplicate using the Nanodrop 8000 instrument in which
the EB buffer (Qiagen) that had been used for elution in the miniprep was used as blank
reagent. Plasmid DNA samples were sent for Sanger sequencing to Eurofins MWG Operon
(Louisville, Kentucky, USA).
Table 2.6: Synthetic constructs of FMDV used in this study
Serotype Sample Name FMDV Isolate Name Topotype
A
sA-1 A22 Iraq 24/64 Asia
sA-2 A24 Cruzeiro Euro-SA
sA-3 A Arg 2/2001
sA-4 A Arg /87
sA-5 A Iran 1/96 Asia
sA-6 A22 Iran/99 Asia
O
sO-1 O1 BFS 860 Euro-SA
sO-2 O1 Manisa ME-SA
sO-3 O TAW 10/97 Cathay
C
sC1 Noville C1 Noville
sC3 Resende C3 Resende Euro-SA
Asia1
sAsia-1 PAK Asia1 Pak 1/54
sAsia-1Shamir Asia1 Shamir
SAT1
sSAT1 KEN 4/98 SAT1 KEN 4/98
sSAT1 BOT 1/68 SAT1 BOT 1/68 III
SAT2
sSAT2 ZIM 7/83 SAT2 ZIM 7/83 G1
sSAT2 SAU1/2000 SAT2 SAU 1/2000 G2
SAT3
sSAT3 BEC 1/65 SAT3 BEC 1/65 I
sSAT3 ZIM 4/81 SAT3 ZIM 4/81 II
2.3.2.2 NanoChip400 electronic microarray
All the microarray detection and serotyping experiments were performed in a NanoChip
400 electronic microarray platform (Nexogen, San Diego, California, USA). Electronic mi-
croarray technologies have been described in much more detail in peer-reviewed publica-
43
2.3. MATERIALS AND METHODS
Table 2.7: Foot-and-mouth disease virus strains used in this study.
Serotype Sample Name Topotype Top BLAST
Hit Accession
% Coverage % BLAST
Identity
Top BLAST hit isolate
A
A22 Iran1/96 Asia AY593791.1 100 98 A/IRN/1/96
A ARG 2/2001 AY593786.1 100 99 A ARG 39111_Cor_Gpaz
A ARG/87 Euro-SA KX002196.1 100 93 A ARG 39111_Cor_Gpaz
A COL/85 Euro-SA AY593794.1 100 100 A Sabana/COL/85
A Iran 22/99 Asia EF208772.1 79 96 A/Afyon/TUR/245/06/03
A22 Iraq 24/64 Asia AY593763.1 100 100 A22 Iraq 64 iso86
A24 Cruzeiro/Bra/55 Euro-SA AY593768.1 100 99 A24 Cruzeiro iso71
O
O1 Manisa/TUR/87/67 ME-SA AY593823.1 100 99 O1 Manisa iso87
O TAW 10/1997 Cathay AY593835.1 100 99 O Taiwan 97 iso106/112
O UKG 1/2001 KM257062.1 100 100 O UKG/1558/2001
O1 BFS/1860 Euro-SA JX869188.1 100 100 O BFS 89/68
C
C1 Noville Euro-SA AY593804.1 100 100 C1 Noville/Switzerland/56/65
C3 Resende Euro-SA AY593807.1 100 99 C3 Resende/Brazil/55
Asia1
Asia1 PAK 1/54 AY593795.1 100 100 Asia1 PAK iso3
Asia1 Shamir JF739177.1 100 100 Asia1/Shamir/89
SAT1
SAT1 KEN 4/98 DQ009721.1 89 100 SAT1 KEN 5/98
SAT1 BOT 1/68 III AY593845.1 100 99 SAT1 BOT 1/68 iso 47
SAT2
SAT2 ZIM 5/81 EF134951.1 88 100 SAT2 ZIM 5/81
SAT2 SWA 1/69 KU821592.1 100 87 SAT2/ZAM18/2009
SAT2 SAU 1/00 G2 AY297948.1 93 99 SAT2 SAU/6/00
SAT2 ZIM 10/91 AF540910.1 99 93 SAT2 ZIM/7/83
SAT3
SAT3 BEC 1/65 I AY593853.1 100 100 SAT34 Bech iso23
SAT3 ZIM 4/81 II KX375417.1 100 99 SAT3/ZIM/4/1981
tions (Miller and Tang, 2009; Lung et al., 2012) and in the introductory chapter of this
thesis.
Samples of 3.5 µL of biotinylated oligonucleotide probes (5 µM in ultrapure water; 250
nM working concentration) were prepared in 66.5 µL of a 50mM histidine buffer containing
0.05% ProClin as described before (Lung et al., 2012). The probe and sample addressing
layout of every cartridge was programmed to test multiple PCR products simultaneously
with multiple capture probes by duplicate. In total, 117 capture probes were tested with
FMDV synthetic constructs, including 12 pan-FMDV detection probes (positive controls
for the presence of FMDV), 104 serotyping probes, and 1 non-specific binding probe (neg-
ative control). The biotinylated capture probes were electronically addressed at 350 nA/pad
for 30 s to hydrogel pads containing streptavidin. Each FMDV synthetic construct sample
was prepared by mixing 8.75 µL of RT-PCR product with 61.25 µL of high salt buffer (Nex-
ogen). FMDV synthetic samples were electronically addressed to the array with a current
of 88 nA/pad for 60 s.
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The fluorescent reporting of the hybridization of the amplicons with the capture
probes was performed with a locked nucleic acid (LNA) reporter probe (Integrated
DNA Technologies, Coralville, Iowa, USA). The locked nucleic acid probe is use-
ful for discriminating closely related targets such as the amplicons developed for this
FMDV serotyping assay (You, 2006). The sequence of the locked nucleic acid was:
5’-/5Alex647N/TGT+CA+AGCG+AT+AT+ACT+GC-3’, where the bases in bold letters
contain the locked nucleic acid modification. Locked nucleic acids have methylene bridges
that keep hybridization stable at high temperatures. The reporter probe used in this assay is
complementary to the mutseq tag of the FMDV reverse primer sequence. The hybridization
of the reporter probe to the mutseq tag of the synthetic construct products started at a tem-
perature of 24◦C for 20 seconds with 2◦C increments up to 60◦C. After each temperature
increment, a wash with Low Salt Buffer (Nexogen) was performed. Images were taken and
fluorescence intensity (FI) was measured automatically by the NanoChip400 instrument.
Electronic microarray experiments had a run time of 3 hours and 31 minutes.
2.3.3 Testing the assay with viral RNA
Details on the viral propagation and viral RNA extraction work can be found in Ap-
pendix A. Due to the highly contagious nature of FMDV that work was performed in the
biocontainment level 3 facility of the National Centre for Foreign Animal Disease (NC-
FAD) by personnel of the Vesicular Disease Unit. The strains selected for the initial labora-
tory evaluation were twenty-three FMD viruses representing all seven serotypes and from
different geographical origins (Table 2.7).
2.3.4 Reverse-transcriptase PCR amplification
The reaction conditions listed here are the same conditions used for the assay published
by Erickson et al. (2017) in which a volume of 50 µL was prepared for each reaction. A
master mix containing 19.5 µL of UltraPure water, 25 µL of 2X Superscript III Reaction
Mix containing 0.4 mM of each dNTP and 3.2 mM MgSO4 (Invitrogen Life Technologies,
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Burlington, Ontario), 10 µL of the SHC primer pool mix (Table 7), 2 µL of SuperScriptIII
Platinum Taq DNA polymerase (Invitrogen Life Technologies) and 1 µL of RNA template.
The following temperature profile was used for RT-PCR amplification: 15 min at 55◦C
(reverse transcription), 2 min at 94◦C (inactivation of reverse transcriptase / activation of
Taq polymerase), followed by 35 cycles of 30 s at 94◦C (denaturation) and 1 min at 50◦C
(annealing) and 1 min at 68◦C (elongation) followed by a final extension of 5 min at 68◦C.
RT-PCR results were analyzed by capillary electrophoresis in a QIAxcel system (Qiagen,
Toronto, Ontario) in the case of the synthetic DNA constructs, or by gel electrophoresis
on a 1% agarose gel and visualized with SYBR R© safe DNA gel stain (Invitrogen Life
Technologies) by Mr. Mathew Fisher at the NCFAD in the case of the viral RNA samples.
2.3.5 Electronic microarrayfor testing viral RNA
The microarray detection and serotyping experiments were performed in the NanoChip
400 electronic microarray platform (Nexogen). Viral RNA samples and probes were pre-
pared in a similar fashion than in subsubsection 2.3.2.2 (NanoChip400 electronic microar-
ray). The number of probes for each serotype that were used for validation with viral RNA
can be found in Table 2.8.
Table 2.8: Number of probes per serotype and probe category used in NanoChip400 elec-
tronic microarray experiments with viral RNA.
Serotype Number of probes
Pan-FMDV 3
A 12
O 19
C 8
Asia1 6
SAT1 9
SAT2 13
SAT3 6
Negative control 1
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2.3.6 Data analysis and visualization
Raw fluorescence intensity measurements were exported as Microsoft Excel files (*.xls)
from the Data Viewer proprietary software application of the NanoChip 400 instrument
(Nexogen). The experimental data were processed using the R statistical computing lan-
guage (R Core Team, 2016). NanoChip400 data was reshaped so that all observations were
in rows and all variables were in columns, a format that is also called tidy data (Wickham,
2014, 2016). The positive-to-negative ratio (PN) was calculated for each probe by dividing
the mean FI value of the viral RNA samples by the FI of the Non-template control (NTC)
(Lung et al., 2011, 2012, 2013).
2.3.7 Empirical determination of optimal temperature and PN ratio
The trade-off between sensitivity and specificity at different temperatures and PN ratio
cutoffs was analyzed for the electronic microarray results. First, the distributions of PN
ratios at all temperatures were analyzed to identify those temperatures where negative PN
ratios were observed. Negative PN ratios were considered artifacts of the NanoChip400 and
a sign of lack of hybridization between probes and amplicons. Therefore, data recorded at
56◦C, 58◦C, and 60◦C were removed from the analysis because they contained negative
PN ratios. As a result, further sensitivity and specificity analyses were performed only
on data from temperatures from 24◦C to 54◦C. Receiver operating characteristic (ROC)
curves (Lusted, 1971; Zweig and Campbell, 1993; Greiner et al., 2000) were generated
after computing binary scores that assigned a value of 1 if the sample was both detected and
subtyped at a given PN ratio cutoff, and a value of 0 if the sample was either not detected
or not subtyped. ROC curves were plotted with the plotROC package of the R statistical
computing language (Sachs, 2016). The area under the curve (AUC) was calculated for the
ROC curves of all temperatures from 24◦C to 54◦C.
Heatmaps PN ratio data were generated using a continuous gradient of black and red
colour using the TreeView software (Eisen et al., 1998), and the impact of changing the
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positivity cutoff in the heatmap was explored with an interactive application that was devel-
oped using the shiny package of R (Chang et al., 2016) that uses the rbokeh visualization
package of R (Hafen and Continuum Analytics, Inc., 2016) (Figure 2.10). Probe-sample
hybridizations were considered positive if the positive-to-negative ratio was equal or greater
than an empirically determined threshold analyzed with the ROC analysis and visualized
with the aforementioned applications. The FI results at all the washing temperatures were
analyzed, and the heatmap visualizations of PN ratio data at 54◦C are reported here.
2.4 Results
2.4.1 Assay design and in silico evaluation
2.4.1.1 FMDV primer coverage
Forward primer pool Although the RT-PCR reaction developed by Erickson et al. (2017)
included primers for the detection of seven viruses of swine, since the focus of this thesis
is on the characterization of FMDV serotypes, only the coverage of FMDV sequences by
FMDV primers was analyzed in this work. In combination, the nine primers of the forward
FMD primer pool matched 286 out of 288 FMDV complete genome sequences (99.3%)
with 0, 1, 2 or 3 mismatches (Figure 2.2a). There were only two sequences that were
not covered by the forward primers. The first of those strains was serotype Asia1 isolate
IND 21-89 (GenBank accession number DQ989316.1) that was originally obtained from
a buffalo host in India in 1989 (Mohapatra et al., 2008). The reason the forward primers
do not match in silico that region of that particular FMDV genome is that the sequence
contains a segment of 582 Ns (undefined nucleotides) which includes the forward primer
region. The second strain that was missed by the forward primer pool was the serotype C
isolate C-S8p260d999 (GenBank Accession number DQ409184.1). This particular isolate
was used in a study where FMDV strains with deletions in their genomes were produced to
better understand viral evolution (García-Arriaza et al., 2006). This genome is much shorter
than the typical FMDV complete genome as it only has a length of 7,116 base pairs, and its
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sequence has gaps in the multiple sequence alignment in the binding region of the forward
primers. The design of this primer pool is reflected by the patterns of database coverage
of the 9 primers of the pool were very different. Primers complement each other since
some primers cover the sequences of FMDV strains that other primers do not cover, and
there is some serotype-specificity for some of those oligonucleotides (Figure 2.1b). This
design for strategically capturing the maximum number of strains possible with relatively
few molecules is further supported by the patterns of mismatch distributions within and
between the primers (Figure 2.2a).
Reverse primer The reverse primer contained 2 degenerate bases which result in 4 se-
quence variants. Considering all four primer variants, the reverse primer covered 287 out of
288 sequences with 0, 1, 2 or 3 mismatches (Figure 2.3). The only whole genome sequence
that the reverse primer did not cover with the above criteria was isolate Asia1-2 Israel 3-63
iso6 (GenBank Accession AY593796.1). This Israeli virus was isolated in 1963 and the
sequence was submitted to NCBI by the African Swine Fever Research Unit of the Plum
Island Animal Disease Center (Carrillo et al., 2005). As it was the case with the forward
primer pool, the design of the reverse primer was intended to cover the maximum number
of sequence variants as possible with few modifications. The patterns of database coverage
reflected this design since those patterns were considerably different between the 4 variants
of the degenerate reverse primer. Another way in which the design of the reverse primer re-
flects the goal to capture the diversity of FMDV sequences is that the reverse primer variants
complement the coverage of each other to some extent (Figure 2.3b).
2.4.2 Primer specificity
In the study by Erickson et al. (2017), the FMDV primers did not amplify 10 clinical oral
negatives nor did they amplify 12 non-target viruses and bacteria. In the present study, the
specificity of the swine high consequence assay multiplex PCR primers was tested in silico
for their potential cross-reactivity and amplification of picornaviruses other than FMDV,
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(a) Differences in the number of strains with 0, 1, 2, 3 and 4 or more mismatches between
the 9 FMD primers of the forward primer pool.
(b) Heatmap depicting coverage of the FMDV whole genome sequence database by each
primer of the forward primer pool. Results are depicted using a red-black scale. The more
intense the red colour, the fewer the mismatches. Strains are divided by FMDV serotype.
Figure 2.1: Coverage of the forward primer pool represented as (a) the distribution of num-
ber of mismatches, and (b)the number of mismatches per serotype. Primers 9-1 and 9-2 are
two variants of the same degenerate primer.
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(a) Distribution of mismatches along the nucleotide positions of the forward primer pool.
(b) Distribution of mismatches along the nucleotide positions of the reverse primer.
Figure 2.2: Distribution of mismatches along the nucleotide positions of the forward primer
pool and the reverse primer.
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(a) Differences in the number of strains covered with 0, 1, 2, 3, 4, 5 or 6 mismatches
between the 4 variants of the reverse primer FMDV2BRev4026-Sdeg2.
(b) Heatmap depicting the FMDV strains covered by each variant of the reverse primer
FMDV2BRev4026-Sdeg2. Strains are divided by FMDV serotype. The Y axis scales were set
independently for each serotype.
Figure 2.3: Coverage of the reverse primer pool represented as the distribution of number
of mismatches and the number of mismatches per serotype.
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and for potential cross-reactivity with hosts of FMDV. The results of those evaluations are
presented below:
2.4.2.1 FMDV primer pairs vs. non-FMDV picornaviruses
There was cross-reactivity predicted in silico of FMDV primer pairs vs. non-FMDV
picornaviruses. This is expected since these primers target a highly conserved region of the
FMDV genome and of picornaviruses.
2.4.2.2 All specific primer pairs vs. non-FMDV picornaviruses
As expected, the SVDV-specific primers matched SVDV sequences, although this hap-
pened at thresholds of 4, 5 and 6 mismatches. There were zero matches of Besides those
matches against SVDV, there were zero non-FMDV picornaviruses matched by the other
specific primer pairs of the SHC assay reported with e-PCR.
2.4.2.3 Non-specific primer pairs vs. FMDV and non-FMDV picornaviruses
Specificity tests were performed with re-PCR for a range from 1 to 10 mismatches to
search if non-specific primer pairs could match FMDV sequences. No primer pair hits were
found between all the non-specific primer pairs and FMDV sequences at any of the primer
mismatch thresholds with re-PCR analyses. In the case of the non-specific combinations of
primers vs. the non-FMDV picornaviruses, no primer pairs reported matches at thresholds
of 0, 1, 2 and 3 mismatches. There was only one primer pair match at a threshold of 4 mis-
matches. The predicted match was a 239 bp amplicon from an Enterovirus B that is found
in non-human primates (GenBank accession number: KF648613.1). The matching primer
pair was composed by variant #6 of the FMDV forward primer ( FMD-VP3com980(4)_6)
and the SVDV forward primer (SVDVCV-3C-17a-F-(5875bp)_1). However, there is a mis-
match in the terminal 3’ base of that match, and therefore, amplification would be unlikely.
In addition, the simulation of polymerase chain reaction conditions with Thermo-
BLAST resulted in the prediction of six possible amplicons from four unique non-FMDV
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Figure 2.4: Non-FMDV picornavirus hit found by querying non-specific primer pairs with
e-PCR. This hit resulted from a query of all the non-specific primer pairs with tolerance of
4 mismatches per primer.
picornaviruses. Those predicted amplicons resulted from interactions between primers that
were not designed for the same target virus (Table 2.9). Further analysis of those results
shows that three of those viruses (Human coxsackievirus B2 isolate KOR 04-279, Salivirus
FHB and Hepatitis C virus full-length replicon pFGR-JFH1 RNA, complete sequence) in-
fect humans or non-human primates. The only virus that infects a host of FMDV was the
unclassified kobuvirus strain Kagoshima-2-24-KoV/2015/JPN (GenBank accession number
NC_027918.1). This Japanese virus was found in diarrhoeic calves and it was originally
identified as a novel kobu-like virus by phylogenetic analysis (Otomaru et al., 2016).
The amplification of this predicted 2,781 bp amplicon is unlikely because the hy-
bridization of the forward PRRS_Mtrx_F2_1 primer is weak, although there is complete
matching between the last twelve 3’ bases of the primer and the kobuvirus (Figure 2.5).
In addition, the visualization of the reverse primer hybridization generated with Thermo-
BLAST showed that the 3’ base of the reverse primer does not match the target (Fig-
ure 2.6). Moreover, the primer pair detected in this in silico reaction has two forward
primers (PRRS_Mtrx_F2_1 and FMDV_FWD_pool_2). Since none of these primers have
the mutseq tag, even if the non-specific target was amplified, it would not be detected by
the electronic microarray.
2.4.2.4 All non-specific primer pairs vs. host genomes
Pig genome No hits were reported between the non-specific primer pairs and the swine
genome (Sscrofa10.2 assembly) at 0, 1, 2 and 3 mismatches with e-PCR. Results with a
tolerance of 4 mismatches per primer resulted in the predicted amplification of a 313 bp am-
plicon derived from primer # 8 of the FMD forward primer pool (FMD-VP3com980(4)_8)
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Figure 2.5: ThermoBLAST visualization of the hybridization of primer PRRS_Mtrx_F2_1
vs. cattle kobuvirus Kagoshima-2-24-KoV/2015/JPN (NC_027918). The primer sequence
is represented in dark blue (top), while the kobuvirus genome sequence is represented in
light blue (bottom).
Figure 2.6: ThermoBLAST visualization of the the predicted hybridization of primer
FMDV_FWD_pool_2 vs. cattle kobuvirus Kagoshima-2-24-KoV/2015/JPN (NC_027918).
The primer was identified as a potential reverse primer of the predicted amplification of
the kobuvirus.The primer sequence is represented in dark blue (top), while the kobuvirus
genome sequence is represented in light blue (bottom).
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Table 2.9: ThermoBLAST results of predicted non-specific primers vs. non-FMDV picor-
naviruses. Non-specific pairs are those between oligonucleotides that were designed to
target different viruses.
Forward Primer Forward
Tm (◦C)
Reverse Primer Reverse
Tm (◦C)
Predicted
Amplicon
Size
Predicted Target (Accession)
PRRS_Mtrx_F2_1 59.80 FMDV_FWD_pool_2 50.40 2781 Cattle kobuvirus (NC_027918)
KBH12_6E2ExtREV_1 54.70 PRRS_Mtrx_F2_1 51.40 168 Salivirus (NC_025114)
FMDV_2BRev4026_Sdeg2_3 50.70 VESVSM_2_F_(5101bp) 55.00 1471 Human coxsackievirus B2 (EF174469)
FMDV_2BRev4026_Sdeg2_2 50.70 VESVSM_2_F_(5101bp) 55.00 1471 Human coxsackievirus B2 (EF174469)
KBH12_6E2ExtREV_2 50.40 PRRS_Mtrx_F2_1 51.40 168 Salivirus (NC_025114)
PRRS_Mtrx_R2_2 51.00 PRRS_Mtrx_F2_1 50.20 1259 Hepatitis C virus (AB237837)
and variant #16 of the CSFV primer (KBH12-5E1ExtFWD_16) (Figure 2.7).
Cow genome No hits were reported between the non-specific primer pairs and the bovine
genome (Bos_tarus_UMD_3.1.1 assembly) at 0, 1 ,2 and 3 mismatches. Results with a
tolerance of 4 mismatches per primer resulted in the predicted amplification of a 148 bp
amplicon of chromosome 6 of the bovine genome. This in silico non-specific product was
generated with primer # 6 of the FMD forward primer pool (FMD-VP3com980(4)_6) and
the second variant of the CSFV reverse primer (KBH12-6E2ExtREV_2) (Figure 2.7).
Sheep genome No hits were reported between the non-specific primer pairs and the sheep
genome (Ovis_aries_1.0 assembly) at 0, 1, 2, and 3 mismatches. Results with a tolerance of
4 mismatches per primer resulted in the prediction of the amplification of a 262 bp amplicon
derived from primer # 5 of the FMD forward primer pool (FMD-VP3com980(4)_8) and the
second variant of the CSFV reverse primer (KBH12-6E2ExtREV_2) (Figure 2.7).
2.4.3 Probe coverage
The pan-FMDV capture probes designed for this study provided high in silico cover-
age of the FMDV target sequence database. Twelve highly conserved pan-FMDV capture
probes were evaluated against 335 sequences that contained the highly conserved region
for which these probes were designed. After expansion of the degenerate bases, the total
number of variants of the pan-FMDV probes was 251, and probes covered the majority of
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(a) Predicted 313 bp non-specific product of swine target amplification. In silico evaluation was
performed with e-PCR at a threshold of 4 mismatches.
(b) Predicted 112 bp non-specific product of bovine genome (Bos taurus) target amplification.
(c) Predicted 226 bp non-specific product of sheep genome (Ovis aries) target amplification.
Figure 2.7: Non-specific products generated with non-specific primer pairs vs. host
genomes: (a) Sus scrofa, (b) Bos taurus, and (c) Ovis aries. In silico evaluations for the
three species was performed with e-PCR at a threshold of 4 mismatches. The number in
the middle of the graphic is the number of base pairs between primer sequences in the host
genome.
the sequences in the FMDV common region database Figure 2.8.
Table 2.10: In silico coverage of pan-FMDV and serotype-specific probes against the
database of partial and complete FMDV sequences (n=2,888).
Serotype Number of probes % coverage of database (proportion)
Pan-FMDV 12 98.2 (329/335)
A 12 99.51 (615/618)
O 28 97.45 (1186/1217)
C 9 100.00 (131/131)
Asia1 6 99.16 (355/358)
SAT1 8 99.02 (202/204)
SAT2 34 97.48 (271/278)
SAT3 6 100.00 (67/67)
2.4.4 Probe specificity
2.4.4.1 Pan-FMDV probes
The pan-FMDV probes were evaluated for specificity to FMDV in silico by searching
their sequences against the sequences of non-FMDV picornaviruses. Searches were per-
formed with reverse-electronic PCR (re-PCR) and matches with Equine rhinovirus 3 strain
P313/75 (GenBank accession: AF361253.1) were reported when performing the searches
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Figure 2.8: Heatmap of the in silico coverage of each pan-FMDV probe vs. the database
of sequences with the common probe region (n=335). Probe sequences were expanded
(i.e. degenerate bases were resolved) and searched with BLAST against the common probe
region database. Matches were filtered using criteria such as 80% identity and 75 % query
coverage. The color scale represents the % identity of the BLAST searches of the combined
results of each oligonucleotide vs. the sequences in the database. Results are ordered by
FMDV serotypes.
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with 2 gaps. However, it is predicted that the risk of false positive reactions of the pan-
FMDV probes with those equine viruses in vitro is very low since no amplification was pre-
dicted for that equine picornavirus according to the in silico analysis of the FMDV primers
and the SHC primers.
2.4.4.2 Serotype-specific probes
The serotype-specific probes were tested in silico for specificity by searching their
sequences against databases of the six heterologous serotypes combined. The serotype-
specific probes showed high specificity in silico to each of the serotypes, although some
cross-reactivities were detected.
2.4.5 Amplification of synthetic constructs and viral RNA
The singleplex FMD RT-PCR assay amplified all of the 19 synthetic constructs of
FMDV strains from different geographical locations and years. There were no non-specific
products generated by the singleplex RT-PCR assay that was used to amplify the synthetic
constructs that were screened with the capture probes. The twenty-three viral RNA samples
were successfully amplified with RT-PCR using the SHC multiplex primers with optimized
reaction conditions work performed by Mr. Mathew Fisher, NCFAD) (Figure 2.14). The
RT-PCR did not generate non-specific products.
2.4.6 Detection and serotyping on electronic microarray
A total of 12 pan-FMDV probes were tested with amplicons derived from the 19 syn-
thetic FMDV constructs. All the synthetic constructs reacted with the pan-FMDV probes.
As it can be seen in Figure 2.9, pan-FMDV probes A, B, and C detected all the synthetic
constructs. However, after in silico analysis, pan-FMDV probes A, D, and E were chosen
for the electronic microarray with viral RNA, due to the higher coverage of these probes
in combination. This decision was made in the event strains that were not originally repre-
sented in the panel of synthetic constructs.
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In addition to the pan-FMDV probes, a total of 93 serotype-specific capture probes and
1 non-specific capture probe were tested on the electronic microarray platform. Serotype-
specific probes reacted with and correctly typed the 19 synthetic construct amplicons (Fig-
ure 2.9), although not all the serotype-specific probes yielded hybridizations with a PN ratio
above the threshold of 2.0.
In this preliminary testing, six serotype-specific probes showed cross-reactivity with
other serotypes. These probes were: FMD A6 (cross-reacted with sample C3 Resende),
probe O-149 (cross-reacted with sample sA-4), probe FV-O-166 (cross-reacted with sample
sA-4), probe FV-O-169 (sA-3, sA-5, C3 Resende). Probes FV-Asia-206 (cross-reacted with
samples sA-3 and sA-4) and probe FV-Asia-040 (cross-reacted with samples sA-4, sO3 and
Sat3 Zim). These cross-reactivities were not predicted by applying the stringent criteria to
the BLAST results. However, the results were predicted with e-PCR.
The 23 RT-PCR products generated with viral RNA were successfully detected with the
pan-FMDV probes (Figure 2.14), and the twenty-three strains were correctly typed with the
electronic microarray assay at a temperature of 54◦C using a PN ratio of 2 as a cutoff for
positive results (Figure 2.14).
2.4.6.1 Determination of the optimal temperature and PN ratio
In this study, a touch-up protocol in which temperature was raised by increments of 2◦C
was used. This touch-up protocol was different than the touch-down protocol used in the
electronic microarray assay by Erickson et al. (2017) in which temperature was decreased
and PN ratios were determined from the final temperature wash. In this study, the results
from all the experiments at all the temperatures for which results were obtained were eval-
uated. An initial visual inspection of the distribution of PN ratios showed that at 56◦C,
58◦C and 60◦C there were many results that had negative PN ratios. Therefore, those re-
sults were discarded from the analyses and the distributions of PN were compared for all
temperatures from 24◦C to 54◦C. Although all the temperatures had PN ratio distributions
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that were skewed to the left due to the majority of results having PN ratios that spanned
a narrow range, PN distributions varied in the number of results with PN ratios that were
higher than 5, with the most extreme case being the data at 54◦C (Figure 2.11), in which
signals (amplicon-probe fluorescence intensity) were maximized in relation to the noise
(non-template control fluorescence intensity). Furthermore, the sensitivity and specificity
trade-offs for all PN ratios at all the temperatures were evaluated by generating ROC curves
for the PN ratio results of all the computed serotyping PN results at different temperatures.
The PN ratios at 54◦C had the largest area under the curve. (Figure 2.12. Visual inspection
of the ROC at 54◦C showed that a PN ratio between 2 and 2.25 is likely to maximize de-
tection and subtyping at that temperature (Figure 2.13). In this work, a PN ratio of 2 was
chosen for the visualization of microarrays results because more weight was assigned to
sensitivity than specificity.
2.5 Discussion
2.5.1 Comparison of testing synthetic constructs and viral RNA
The simultaneous detection and serotyping assay was developed in the NanoChip400
electronic microarray in two stages: testing with 19 FMDV synthetic constructs for pre-
liminary capture probe screening, and testing with 23 viral RNA samples for validation.
Both testing panels represented the seven serotypes of FMDV and, to some degree, the
genetic diversity of the virus. One negative control sample was tested in each assay de-
velopment stage. The assay was developed and screened using synthetic constructs in the
biosecurity level 2 facility at the Lethbridge Laboratory of the National Centres for Animal
Disease (NCAD) of the CFIA. Synthetic constructs were designed and tested as an alterna-
tive to using FMDV viral RNA for prototyping the assay when using the real virus in the
biosafety containment level 2 facilities of the Lethbridge Laboratory was not a possibility
due to biosecurity regulations and policies. Testing virus detection assays with synthetic
constructs is a strategy that has been used before in other studies (Banér et al., 2007).
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Figure 2.9: Heatmap of NanoChip 400 electronic microarray results of pan-FMDV and serotype-
specific capture probes against nineteen synthetic constructs at 54 ◦C. Rectangles in red are results
with a positive-to-negative ratio equal or greater than 2.0. The positive-to-negative ratio results
of pan-FMDV and serotype-specific probes are highlighted in yellow rectangles for each of the
serotypes, and in the case of pan-FMDV probes for all the serotypes.
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Figure 2.10: Example of the interactive application for the visualization of the results of
NanoChip400 experiments.
2.5.2 In silico coverage of FMDV databases
A challenge for the development of detection assays for FMDV and other single
stranded RNA viruses is the rapid evolution and the high amount of genetic variation present
in the population of the virus. Molecular detection assays such as polymerase chain reac-
tion (PCR), real time PCR, and microarrays are typically designed to either target a highly
conserved region of the FMDV genome (which is useful for detection) (Ambagala et al.,
2016), or to capture the high genetic diversity of the FMDV genome by designing degen-
erate primers or primer pools, whic was the strategy used in Erickson et al. (2017) and the
present study. The evaluation of the forward primer pool and the reverse primers showed
that the design of those molecules resulted in coverage of the different strains and serotypes
of the sequences of the FMDV sequence database that was used to assess in silico sensitiv-
ity.
A common challenge with molecular and serological detection assays is that they need
to be updated as new strains emerge. In the case of molecular detection assays, two factors
are important for maintaining the high sensitivity and specificity of microarray assays for
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Figure 2.11: Distributions of Positive-to-Negative ratio (PN) ratios for each of the different
reporting temperatures of the electronic microarray FMDV detection and serotyping assay.
PN ratios represent data from all the NanoChip400 experiments performed with viral RNA
at the NCFAD. Distributions with longer tails indicate a wider range of PN ratios, and thus
higher signal-to-noise. The distributions were plotted as ridgeline density plots with the
ggridges package (Wilke, 2017) of the R statistical computing language (R Core Team,
2016).
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Figure 2.12: ROC curves of FMDV serotyping results with viral RNA. Each point in the
ROC curves represents the trade-off between specificity (False positive fraction), and sen-
sitivity (True positive fraction) for positive-to-negative ratio results at each of the temper-
atures of the NanoChip400 touchdown protocol (excluding 56◦C, 58◦C, and 60◦C due to
the presence of negative PN ratios). Labels above the curves represent the temperatures in
degrees Celsius. The area under the curve (AUC) was calculated for all the ROC curves.
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Figure 2.13: ROC curve of serotyping data at 54◦C. Points represent the trade-off between
specificity (False positive fraction), and sensitivity (True positive fraction) at different PN
ratio cutoffs which were included to illustrate the effect of choosing high or low cutoff
values for determining which results are positive and which results are negative. A perfect
test has an area under the curve value of 1, while the ROC curve for this figure shows
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Figure 2.14: Heatmap of PN ratios of electronic microarray results. Results in the red scale
represent positive results while results in black represents negative results
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the detection and serotyping of viruses:
1. The continuous addition of sequences to publicly available repositories such as Gen-
Bank (National Center for Biotechnology Information), the European Nucleotide
Archive (European Molecular Biology Laboratory) and the DNA Databank of Japan.
2. The emergence of new variants of the virus in the field that may or may not have their
sequences deposited in said public repositories.
In the case of the first factor, there are solutions being developed by research groups
around the world to automate the addition of sequences and curation of metadata. Websites
such as the Virus Pathogen Resource (ViPR; viprbrc.org) can help researchers in human
and veterinary virology to have curated, up-to-date databases with unique sequences that
can be used for the evaluation and updating of databases. In the case of the second factor,
the design of a molecular assay that includes the detection of broader groups can be helpful
when addressing the emergence of new variants or subtypes of viruses. Similar approaches
have been achieved using a panviral microarray that helped to discover new viruses such
as the SARS coronavirus (Wang et al., 2002). However, due to the high genetic variation
within the serotypes designing capture probes for testing with the electronic microarray
may be more challenging.
2.5.3 Serotype specificity
Although some probes cross-reacted with samples from different serotypes in vitro, they
can be removed from the assay or used as signatures for more than one serotype. Observed
cross-reactivities were not predicted with the stringent criteria for filtering BLAST results
for predicting hybridizations. Relaxing the match criteria can help predict the specific hy-
bridizations. Using other alignment algorithms can help to improve the accuracy of the
predictions. In this study, the e-PCR tools were better at predicting cross-reactivities than
the BLAST-based method.
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In this work different programs were evaluated for the in silico testing of primers and
probes because the evaluation of oligonucleotides is one of the most commmon and im-
portant tasks for designing detection and subtyping assays. Examples of tools that are
useful for this purpose include NCBI’s PrimerBLAST and electronic PCR (e-PCR) and re-
verse PCR (re-PCR) command line tools (Schuler, 1997; Rotmistrovsky et al., 2004). In
this study, in silico predictions performed with e-PCR and Thermo-BLAST suggested that
it is unlikely that the FMDV PCR assay will cross-react vs. host genomes or any other
Aphthovirus or Picornavirus. A caveat to those predictions is that that work was based
on computational simulations, and the results may differ when tested in vitro. Also, there
may be novel viruses of those genera and families or new variants as a result of evolution
that have not been sequenced or deposited in publicly available databases and which might
cross-react with the oligonucleotides in vitro. Although the in silico predictions suggest that
it is unlikely that cross-reactivity of any of the pan-FMDV and/or serotyping probes will be
observed with other aphtoviruses or picornaviruses, the pan-FMDV probes and serotyping
probes were still verified against the other genetically related viruses. Although the e-PCR
suite of tools was recently discontinued by NCBI, other commercial tools such as Geneious
can perform similar tasks. Recently developed tools such as Oli2Go can help scientists
to perform evaluation and design of oligonucleotides for multiplex PCR assays and mi-
croarray while performing specificity checks against bacteria, viruses, fungi, invertebrates,
plants, protozoa, archaea and environmental samples (Hendling et al., 2018). An example
of tools that were conceived for the design of oligonucleotides to detect and genotype highly
variable targets is PriMux (Hysom et al., 2012), in which a multiple sequence alignments
are not necessary since the search is based on k-mers. like ThermoBLAST (SantaLucia,
2007) can also help to predict results taking in consideration thermodynamic parameters,
and not only sequence complementarity.
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2.5.4 Evaluation of assay cross-reactivity against other viruses
In silico evidence presented in this work predicts that the FMDV primers in the RT-PCR
and the microarray probes of the FMDV serotyping assay are specific to FMDV and that
they should not detect other genetically related viruses with sequence information available,
nor should they detect host genomes. As mentioned in the introduction chapter of this the-
sis, the FMDV detection and serotyping assay here reported was conceived as a companion
test to a multiplex assay to detect and differentiate seven indigenous and exotic viruses that
infect swine. Furthermore, according to the results presented by Erickson et al. (2017) there
was no in vitro cross-reactivity of the FMDV primers and the FMDV detection probes with
any of the other 6 viruses of the SHC assay.
2.5.5 Data analysis tools and methods for electronic microarray results
Previous studies that have used electronic microarray data for the detection and typing
of viruses used the positive-to-negative ratio as a the metric for determining which probe-
target hybridizations were positive (Lung et al., 2012, 2015, 2016; Erickson et al., 2017).
The advantage of the PN ratio is that it is a metric that is easy to interpret which makes
it user-friendly. Electronic microarrays are not well represented among the data analysis
software that are specifically designed for microarray data, in contrast to platforms such
as Affymetrix for which many data analysis tools exist, including many BioConductor R
packages. Although the R script written by Gall et al. (2009) was designed to extract
data from NanoChip400 experiments, said script was hard to debug and to adapt to data
generated in this study, something that was not made easier by the fact that the comments
in the code were written in German language only. Unfortunately, no publicly available
repository in Github or Bitbucket for the maintenance of said code seems to exist. Another
tool for the analysis of microarrays for the detection of multiple pathogen was the DetectIV
R package (Watson et al., 2007), which was found useful for other microarray platforms for
the detection of pathogens, but the options of visualizations that it included were limited to
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bar graphs and custom work would needed to be done for creating heatmap visualizations.
2.5.6 Comparison versus other assay methods
There is strong interest from the livestock industry to implement rapid, sensitive and
specific tests for the detection of animal viruses. In particular, the research and develop-
ment of diagnostic tests for FMDV is growing at a fast pace. Although next generation
sequencing (NGS) is a much more efficient method to detect viruses, particularly for se-
quencing the small whole genome of FMDV, microarrays have a niche in the rapid detection
of animal viruses due to automated technologies that can produce rapid tests. In addition,
the oligonucleotide probes can be used for in silico serotyping of new FMDV strains. This
is a technique that has been used in other tools such as the Salmonella In Silico Typing
Resource (SISTR) (Yoshida et al., 2016) and GeneSippr (Lambert et al., 2015) which char-
acterize serotypes of Salmonella and E. coli, respectively.
2.5.7 Analytical tools
As much as microarrays provide advantages over other methods due to being able to
test multiple samples against many probes simultaneously, the data generated by microar-
rays is complex and can be challenging to analyze and interpret. Data from microarray
experiments such as the ones presented in this work have multiple dimensions. Many data
analysis tools for pathogen detection microarrays have been developed for the Affymetrix
platform. For example, using solutions based on the R statistical computing language (R
Core Team, 2016) or other computing languages like Python can greatly help to accelerate
the analysis of microarray data. The DetectIV package for the (Watson et al., 2007) was
developed with the specific purpose of processing and visualizing results from pathogen de-
tection microarrays from different platforms, although electronic microarray datasets were
not considered. DetectIV is suitable for showing results of individual microarray experi-
ments, but it is difficult to visualize aggregated results from multiple experiments with it,
unless the user has a better knowledge of processing multiple datasets by programming in
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R using data structures such as lists and uses functions that operate on those lists.
Although in the paper by Gall et al. (2009) the authors wrote a script in the R statis-
tical computing language to automatically process data generated with the NanoChip400
platform, the script is not adapted to other NanoChip400 protocols. Heatmap visualiza-
tion tools such as TreeView (Eisen et al., 1998) have existed for many years and have been
widely used for the analysis and visualization of microarray data. However, custom tools
for visualization of electronic microarray datasets and other datasets can allow the users to
learn more relevant information about their data if they do not work on some of the more
established microarray platforms such as Affymetrix. In the context of microarrays for
virus detection and differentiation, the analysis of data using cutoffs to determine positive
or suspect results is often necessary, particularly for virus subtyping assays. Unfortunately,
investigating multiple positivity thresholds and seeing their impact on the heatmap visual-
ization is a tedious task in TreeView. This underlines the need for developing and using
customized analysis tools that are tailored to the specific needs of scientists who use dif-
ferent protocols in the NanoChip400 platform and other pathogen detection technologies.
The current explosion in bioinformatic tools and in computer programming skills being
acquired by bioinformaticians, but also by biologists and technicians will contribute to the
development of tailored solutions for different research and development teams.
2.5.8 Future directions
The detection and serotyping assay here presented was only tested in vitro with twenty-
three viral RNA samples, and validation with more samples would be required. Another
improvement that can be performed on this assay is the determination of the limit of detec-
tion for serotyping of FMDV. The recent publication by Erickson et al. (2017) reported that
the limit of detection for FMDV was 1,000 copies/µL, and an interesting follow up to that
and this study would be to test how the limit of detection impacts the performance of the
serotyping assay.
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The characterization of the serotypes of FMDV is a very important step in the emer-
gency response to an outbreak. Although the NanoChip400 is a highly automated plat-
form, fully automated technologies have the potential to be even more useful for veteri-
nary diagnostics by streamlining the process from sample to results even more. Besides
the examples of fully automated arrays discussed in (subsubsection 1.3.7.7) of this thesis,
an Israeli company called Savyon Diagnostics has developed the NanoCHIP Analyzer, a
fully automated electronic microarray platform that is the successor of the NanoChip400,
and that only requires the user to load the PCR plate, reagents and cartridge (http://
savyondiagnostics.com/product/nanochip-xl-analyzer/; accessed: 2018-02-06).
Examples of assays that have been developed by that company for that platform include
an assay for detecting the Zika, dengue virus, and Chikungunya viruses in human serum
and plasma (http://savyondiagnostics.com/product/nanochip-zikvdenvchikv/:
accessed: 2018-02-06).
In countries where diagnostic laboratory services are not readily available, portable de-
vices for detecting and serotyping could be an effective solution for characterization of
animal viruses such as FMDV in the field. Preliminary work was performed for the design
and development of a prototype instrument to simultaneously detect and characterize the
serotype of field strains. Transferring the assay to a portable technology, or to a point-of-
care device, would address the increasing need in veterinary diagnostics for the develop-
ment and implementation of those technologies. For example, a recently published inter-
national effort led by the Pirbright Institute resulted in the development of a portable ther-
mocycler for the detection and characterization of four FMDV serotypes commonly found
in Eastern Africa (O, A, SAT 1, and 2), although its sensitivity was only of 33/36 samples
(Howson et al., 2017). Examples of lateral flow devices that have been used for the simul-
taneous detection and differentiation of FMDV were discussed in subsubsection 1.3.7.4 of
this thesis, and although those tests are based on antibody detection, it is important to high-
light the need of portable and user-friendly technologies for rapid answer to critical needs
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to protect the nation’s livestock.
Besides moving the assay towards complete automation, miniaturization, or portability,
other actions can be taken to improve the assay. For example, the oligonucleotide sequences
can be reused for new applications. For instance, the oligonucleotides that were tested
in silico and used for the initial laboratory validation of this assay can still be useful as
virus-specific and serotype-specific markers in the analysis of next generation sequencing
data. A more in-depth study of the specificity and sensitivity of the serotype-specific probes
evaluated in this assay when tested with new sequences will be presented in the next chapter
with new FMDV sequences that were not evaluated for this work.
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Chapter 3
A comparison of methods for in silico
characterization of FMDV serotypes
3.1 Abstract
Although molecular nucleic acid detection assays can detect and subtype animal viruses
like the foot-and-mouth disease virus (FMDV), the rapid evolution of this and other RNA
viruses renders those molecular assays and microarrays ineffective if enough mismatches
prevent detectable hybridization between oligonucleotides and the genomes of new field
strains. In this study, the performance of different in silico approaches for the detection and
serotyping of FMDV were evaluated and compared. Publicly available complete FMDV
genomes and next generation sequencing (NGS) data were tested in silico using various
approaches including the evaluation of existing oligonucleotide signatures, the discovery
of serotype-specific signatures de novo, the classification of sequences using k-mer based
taxonomic classifiers, the usage of MinHash-based approaches, and single nucleotide poly-
morphism (SNP) genotyping. Results of the testing of those approaches with genomes that
were not part of the reference datasets are presented. Also, notably, robust single nucleotide
polymorphisms were discovered in this study for each of the seven FMDV serotypes. The
results from this comparison have the potential to aid regulatory agencies, veterinary di-
agnostic laboratories, and animal health organizations to implement in silico strategies for
rapidly characterizing the serotypes of new FMDV isolates and to get high-resolution in-
formation from next generation sequencing reads without the need for de novo assembly.
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3.2 Introduction
3.2.1 Literature Review
Microarrays have higher throughput than many molecular methods for the detection
and sub-typing of viruses due to their capacity to include tens, hundreds, thousands, or
more oligonucleotide features for the detection of viruses and characterization of viral sub-
types. However, microarrays and most molecular detection methods such as PCR may have
reduced sensitivity when challenged with new viral strains that have substantial genetic dif-
ferences from viral sequences used to design those methods. This is because the new strains
could have more nucleotide mismatches with the primers and probes, and those mismatches
may prevent hybridizations between the oligonucleotides and the targets. Multi-pathogen
microarrays and microarrays for the subtyping of viruses can classify samples into differ-
ent categories because oligonucleotide probes are ideally unique signatures for the detection
and classification of the viruses and subtypes of viruses for which they were designed. This
makes these sequences potentially useful as in silico markers for the differentiation of mul-
tiple pathogens or multiple subtypes/serotypes. With the increased use of next generation
sequencing (NGS) for the sequencing of whole genomes, the consideration of other targets
in the genome beyond amplicon targets used in current assays can improve the classification
of samples by their serotype or other metadata categories.
NGS approaches do not typically have those limitations since amplicons of regions of
interest and complete genomes can be sequenced for multiple strains simultaneously and
products can be readily identified. Although genetic sequencing once had the high cost
of $ 95,263,072 per human genome and $ 5,292.39 per megabase in September 2001,
the National Human Genome Research Institute (NHGRI) reported that the cost per hu-
man genome decreased to $ 1,121 and the cost per raw megabase of DNA sequence has
decreased to $ 0.012 on July 2017 (Wetterstrand, 2017). The costs of genome sequenc-
ing have outpaced Moore’s law (i.e. the doubling of computer power every year) since the
introduction of NGS technologies to sequencing centres (Wetterstrand, 2017). One implica-
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tion of those advances is that the amount of information that can be analyzed and the scope
of the analyses that can be performed has spurred the development of bioinformatic tools
which enable researchers to rapidly analyze viral populations and intra-host viral genetic
diversity (Orton et al., 2016).
Regulatory laboratories can benefit from the identification of unique genomic signa-
tures or markers for the characterization of pathogen species, subtypes, serotypes, and other
metadata categories. Those sequence signatures can facilitate the rapid identification and
the understanding of genetic variation and population structure in outbreaks. A notable ex-
ample of how the concept of universal signatures is applied in eukaryotic genomics is the
usage of the cytochrome oxidase I gene as an universal barcode for differentiating species of
eukaryotes (also known as the barcode of life) (Hebert et al., 2003). In the case of bacteria,
the 16S ribosomal RNA gene and have become targets for the characterization of microbial
communities, as this target allows for the characterization of Operational Taxonomic Units
(OTU) thanks to its hypervariable regions.
In veterinary diagnostics, it is important that pathogen detection signatures have high in
silico sensitivity and specificity for the characterization of groups of interest. However, as
the number of sequences from field isolates increases, and higher variation is discovered,
the sensitivity of the assay for detection and subtyping might decrease. Since many of
those oligonucleotides were designed for specific subtypes or subgroups of viruses, it is
possible that those sequence signatures can be used for the in silico characterization of new
sequence data of FMDV and other animal viruses. For example, this idea has been applied
to the characterization of avian influenza virus strains in the FluDB website (Zhang et al.,
2016) where a curated list of eleven PCR and real-time PCR assays (as of December 2017)
presents the evaluation of each oligonucleotide against the continuously updated collection
of curated influenza virus sequences of the Influenza Research Database (www.fludb.org).
Not only does that resource report the number of mismatches of oligonucleotides and new
variants of the virus, but it also reports subtle nucleotide variations between strains since
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it groups genomes in variants according to their matching patterns against the sequences
of the primers and probes of each of the available assays. The idea that oligonucleotide
sequences that have been successfully used in assays in vitro can be used as markers in
silico for subtyping of NGS data is an strategy that has been used before, for example, in
the characterization of Salmonella serotypes in the Salmonella In Silico Typing Resource
(Yoshida et al., 2016).
Metadata-driven comparisons can help to associate sequence features such as single
nucleotide polymorphisms (SNPs) to different metadata categories of pathogens (e.g. epi-
demiological groups or phenotypes). Tools like GenomeFisher or feht (Laing, 2017) can
be helpful in finding those associations since those tools can aid in performing statistical
analysis of the proportion of sequences in a group that have a specific SNP. Those tools
are available for using locally in a Windows system through a graphical user interface
(GenomeFisher) or in the command line on Linux/Unix-based systems (feht). Another
tool for performing this kind of metadata-drive comparisons is the implementation only
available online of metaCATS (Pickett et al., 2013) in the ViPR (Pickett et al., 2012) and
the FluDB (Zhang et al., 2016) databases.
Another commonly used approach to find unique signatures for the characterization
of epidemiological groups is the design of oligonucleotides, since many assays using
those molecules have been developed to discriminate between different viral subtypes or
other epidemiological groups. Whereas in molecular biology scientists usually aim to find
primers and probes that meet certain biochemical parameters such as melting temperature
and avoidance of folding constraints, in computational biology those signatures are text
strings that are not necessarily constrained by the biochemical and thermodynamic proper-
ties that primers and probes must have for in vitro hybridization. For example, in the field of
FMDV genomics, a computational genotyping approach that relied on a machine learning
technique known as support-vector machine was used to find signature strings for each of
the seven FMDV serotypes with 98.45% accuracy (Lin et al., 2008).
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The in silico validation of known markers or signatures with genomes that were not
included in the initial design of an assay can facilitate the assessment of the sensitivity
and specificity of virus or subtype-specific features in predicting the presence and subtype
of new strains. This idea becomes more relevant as NGS methods become more widely
adopted by veterinary and public health diagnostic laboratories. There is the increasing
need in those laboratories to find solutions in which subtypes and other epidemiologically
relevant groups can be characterized as quickly as possible. Recent innovations in bioinfor-
matics have opened the door, for example, to the detection and characterization of samples
from NGS reads without the need of de novo or reference-based assembly. One such inno-
vation that has been gaining wider adoption in the literature and is the utilization of k-mers
for the in silico characterization of microbial genomes and metagenomes. Programs such
as kraken (Wood and Salzberg, 2014) and CLARK (Ounit et al., 2015) classify reads based
on their k-mer composition and what proportion of a read’s k-mer composition is associ-
ated with a given taxon in a reference database. Thus, one potentially can classify FMDV
subtypes by using k-mers that are unique to each of those groups. Classification of NGS
reads with kraken is performed by associating k-mers to NCBI taxonomy ID numbers in
which the lowest common ancestor (LCA) is assigned to the reads. In the case of CLARK,
classification is achieved by using exclusive k-mers that differentiate the taxonomic ranks
or epidemiological groups in question. A limitation of CLARK in comparison to kraken is
that metagenomic classification can only be performed at a single taxonomic/hierarchical
level at a time (i.e. no LCA approach).
Another tool which is a k-mer based signature discovery program is the Neptune bioin-
formatics tool Marinier et al. (2017) that searches signature strings using a k-mer based
approach, and its goal is to find sequence signatures that differentiate an inclusion group
from an exclusion group with high sensitivity and specificity. For example, in Marinier
et al. (2017), signatures were searched for differentiating Enterococcus hirae versus En-
terococcus faecium isolates. Other examples included the search for signature regions to
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distinguish two Listeria monocytogenes serotypes (serotypes 1/2a and 4b), and the location
of signatures of Shiga-toxin producing E. coli (STEC) (Marinier et al., 2017).
Recently, other approaches that use k-mers for characterizing genomes and
metagenomes have emerged. One of those approaches is the adoption of the MinHash
algorithm in comparative genomics and metagenomics studies. MinHash is a computa-
tional technique that was originally developed for estimating the similarity (i.e. the resem-
blance) and the containment (i.e. how much of one document is shared with another) of text
documents (Broder, 1997). This computational method compares sets of strings between
documents and uses the Jaccard index as a distance metric of the resemblance of those sets
of strings. MinHash has been applied to comparative genomics most notably with the mash
(Ondov et al., 2016) and sourmash (Brown and Irber, 2016) software tools. The mash im-
plementation of MinHash has been tested for the real-time detection of pathogens, and the
generation of phylogenetic trees based on Mash distances (Ondov et al., 2016). In addition,
both mash and sourmash allow for the unsupervised classification of reads, which means
that reads can be characterized by comparing sets of k-mers using a similarity distance
measure, and only the content of the sequences is used without a reference genome.
Other techniques for in silico characterization of viral genotypes include SNP genotyp-
ing. Single nucleotide variants that define genetic lineages are known as canonical SNPs,
which is a concept that is more commonly found in the differentiation of genetic lineages
of Bacillus anthracis (Keim et al., 2004), but that has also been used for genotyping other
bacteria such as E. coli (Griffing et al., 2015) and for designing assays for detecting group-
specific SNPs in Francisella tularensis (Birdsell et al., 2014). Besides their application
in bacterial genotyping, canonical SNPs have been discovered and used for the design
of forensic real-time PCR assays to differentiate ebolaviruses (Zaire ebolavirus, Sudan
ebolavirus, Tai Forest ebolavirus, Bundibugyo ebolavirus, and Reston ebolavirus) (Song
et al., 2015).
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3.2.2 Objectives
The objectives of this study were:
1. To evaluate in silico the sensitivity and specificity of oligonucleotides for the differ-
entiation of FMDV serotypes by BLAST and e-PCR.
2. To discover sequence signatures that are specific to FMDV serotypes using the Nep-
tune bioinformatics tool.
3. To evaluate the performance of different taxonomic classifiers in the characterization
of FMDV serotypes.
4. To assess the performance of MinHash-based approaches for the discrimination of
FMDV serotypes based on comparisons of k-mer sets.
5. To discover serotype-specific SNPs with an approach based on multiple sequence
alignments (multiple sequence alignment (MSA)s) and use said SNPs for the charac-
terization of samples that were not used in the original alignment.
3.3 Materials and Methods
3.3.1 Databases
Various sequence databases were used for the analyses of publicly available sequences
and NGS data in the present study (Table 3.1):
3.3.2 Evaluation of existing oligonucleotides for the characterization of FMDV
serotypes
In this in silico analysis the existing serotype-specific probes used in chapter 2 and
the probes from two literature articles were evaluated in silico against the OE database
(Table 3.1). The purpose of analyzing probes from older papers was to assess how sensi-
tive and specific those oligonucleotide signatures were when evaluated against an updated
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Table 3.1: Datasets used for in silico analysis of FMDV complete genomes and NGS
databases in this study.
Database name Abbreviation Analysis Number of
sequences
Description
Oligonucleotide Evalu-
ation
OE Oligonucleotide evaluation
(subsection 3.3.2)
500 Sequences longer than 2000bp re-
trieved from ViPR from the period
of 2014 until 2017.
Sequence Marker Dis-
covery
SMD Identification of signatures
with Neptune (subsubsec-
tion 3.4.1.2)
3,039 Partial and complete sequences
database that was curated in 2012.
K-mer Classification
(training)
KC-training Kraken, CLARK and Mash
(public genomes and NGS)
5,638 FMDV partial and complete
genomes released by NCBI until
the end of 2013.
K-mer Classification
(testing)
KC-testing Kraken, CLARK and Mash
(public genomes only)
2,086 Sequences that were added to the
GenBank database in the period
from 2014 to the end of 2017.
SNP Discovery (train-
ing)
SNP-training SNP discovery 298 All complete genomes downloaded
from GenBank on April 10, 2013.
SNP Discovery (test-
ing)
SNP-testing SNP discovery 391 Sequences retrieved from ViPR: all
complete genomes available until
2017.
database many years later. This was designed as a potential scenario faced by regulatory
and research laboratories that may want to develop assays to detect a highly variable virus
when molecular detection and subtyping methods already exist.
The first article selected for this in silico experiment was Wang et al. (2002), which
presented the development of the landmark ViroChip microarray by the research group of
Dr. Joe DeRisi at the University of California, San Francisco. The second article selected
was Watson et al. (2007) which presented an R package called DetectIV for the analy-
sis of high-density multi-pathogen detection microarray data in which FMDV probes were
included. That software was developed by Dr. Mick Watson during his time at The Pir-
bright Institute in the UK (then known as the Institute for Animal Health) site of the World
Reference Laboratory for FMD. The probes were part of the Virus Detection Array VA1 de-
veloped at that institute and the sequences of those oligonucleotides were downloaded from
NCBI’s Gene Expression Omnibus (Barrett et al., 2013) (GEO; accession GPL5725). The
sequences of the electronic microarray probes and the probes from the two published stud-
ies were searched with both BLAST and an NCBI tool for reverse electronic PCR (re-PCR)
(Schuler, 1997; Rotmistrovsky et al., 2004) against the OE database.
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The sensitivity and specificity of the probes were evaluated using a reproducible work-
flow designed with the snakemake workflow management system (version 4.4) (Köster and
Rahmann, 2012), which was implemented to run this analysis (Figure 3.1) by using blastn
version 2.6.0+ and re-PCR version 2.3.12 on a Linux Mint 17.3 (Rosa) laptop with 4 cores
and 6 GB RAM. A query coverage of 80% was used to determine BLAST hits and e-PCR
hits were determined at 0, 1, 2, 3, 4, and 5 mismatches.
Table 3.2: Number of probes per serotype for each of the studies evaluated against the
updated FMDV database.
Serotype Present study Watson et al. (2007) Wang et al. (2002)
A 12 92 0
O 19 145 10
C 8 26 5
Asia1 6 36 0
SAT1 9 42 0
SAT2 13 58 5
SAT3 6 31 0
3.3.3 Discovery of sequence signatures with Neptune
The de novo identification of sequence signatures for detection and differentiation of
FMDV serotypes was performed using Neptune version 1.2.5 (Marinier et al., 2017). In
the Neptune analysis seven comparisons were performed: the FASTA files containing the
sequences for each serotypes were the inclusion groups, and the FASTA files containing
all the sequences that did not belong to the inclusion serotype were tested as the exclu-
sion groups (Table 3.3). Neptune calculates a score that represents a measure of signature
confidence and that is used to rank signatures by sensitivity and specificity. The score is
the sum of a inclusion group component (i.e. a positive value that represents the sensitiv-
ity with which the signature matches the target group) and an exclusion group component
(i.e. a negative value that represents the sensitivity with which the signature matches the
non-target group). The score when a 100% sensitive and 100% specific region matches the
targets in the inclusion group is 1.0
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Figure 3.1: Diagram of the oligonucleotide evaluation snakemake workflow used for the as-
sessment of the sensitivity of existing signatures for the discrimination of FMDV serotypes
with an updated FMDV sequence database. This diagram is a representation of the di-
rected acyclic graph (DAG) of targets and dependencies used in this workflow for the anal-
ysis of probes from three studies: chapter 2 of this thesis (study: ortega), the study
by Wang et al. (2002) (study: wang_de_risi), and the study by Watson et al. (2007)
(study: watson). Preliminary steps for rePCR analysis are shown: building the famap
mapping file (rule famap) and the fahash hash table (rule fahash) from the reference
database. Those steps were followed by changing the format of oligonucleotide sequences
from FASTA to a table compatible with the rePCR program (rule format_epcr_probes).
Execution of the rules for making the BLAST database (rule makeblastdb) and for run-
ning BLAST searches (rule blast) are also shown. The box labeled as “all” represents the
generation of the final target of the workflow: the generation of rePCR and BLAST tabular
outputs from all the other dependencies. The snakemake system builds the first target in the
Snakefile which contains all the rules to build all the targets in the workflow. In this case,
the “all” target is built first and therefore all the targets in the workflow will be generated.
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Table 3.3: Number of sequences used in inclusion and exclusion groups for each compari-
son in the Neptune analysis.
Comparison Size of inclusion group Size of exclusion group
A vs. not A 769 2,270
O vs. not O 1,227 1,661
C vs. not C 133 2,754
Asia1 vs. not Asia1 359 2,529
SAT1 vs. not SAT1 204 2,684
SAT2 vs. not SAT2 278 2,610
SAT3 vs. not SAT3 69 2,820
3.3.4 K-mer based classification
Classifications of FMDV sequences were performed with kraken (Wood and Salzberg,
2014) and CLARK (Ounit et al., 2015). Both of those programs are fast k-mer based
taxonomic classifier programs with different algorithms, and different in silico analyses
were performed to assess the sensitivity and specificity of classified FMDV sequences by
serotype. The analyses performed with those two programs are described in detail below.
3.3.5 Kraken analyses
The first kraken analysis involved the classification of complete, publicly available
FMDV genomes (KC-testing database) with the reference Kraken database (KC-training
database), instead of the RefSeq-based MiniKraken database which contained only one
FMDV reference genome. The rationale behind using only FMDV sequences was to find
k-mers that are exclusive to each serotype using a database with a larger number and higher
diversity of FMDV k-mers. The KC-training database was built with kraken-build.
The kraken analysis was the classification of seven NGS samples representing the
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seven serotypes of FMDV. Those samples were sequenced by the staff of the genomics
unit of the National Centre for Foreign Animal Disease (NCFAD) of the CFIA (Winnipeg,
Manitoba). The 300 bp reads showed excellent quality metrics measured with FASTQC (An-
drews, 2016), and were pre-processed with PRINSEQ-lite version 0.20.4 by removing 5
bases from both the 5′ end and the 3′ end of each read and setting a minimum length of 80
bp. The trimmed reads were classified with kraken with two subsequent filtering steps:
Filter 1 Because preliminary analyses revealed the presence of bovine viral diarrhea virus
in the FMDV samples, the trimmed reads were filtered with a BVDV database comprised
by all complete and partial BVDV sequences obtained from GenBank on December 2016.
All the reads that did not map to BVDV were processed with filter 2.
Filter 2 The reads that were unclassified in filter 1 were initially screened with FMDV.
The serotypes of the viruses were characterized by the Vesicular Disease Unit of the NC-
FAD. The pre-processed reads were subsampled, assembled de novo with SPAdes (v3.9.0)
(Bankevich et al., 2012), and searched with BLAST after which the closest strains to
each sample had been identified (Table 3.4). In order to run the kraken NGS analyses,
a snakemake workflow was designed and implemented for classifying the FMDV reads
against the KC-training Kraken database, filtering low confidence results, and generating
kraken reports with kraken version 1.1 in the computer cluster of the National Microbiol-
ogy Laboratory (NML) (Figure 3.2).
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Figure 3.2: Diagram of the Kraken classification snakemake workflow used for the analy-
sis of NGS data. This diagram is a representation of the directed acyclic graph (DAG) of
targets and dependencies used in this workflow. Classification was performed for each of
the seven NGS samples from the NCFAD (rule kraken_classify). Filtering of low qual-
ity assignments was also applied after classification (rule kraken_filter), and taxonomic
classification reports were generated for both the unfiltered and filtered classifications (rule
kraken_report). The box labeled as “all” represents the final target of the workflow,
which is the generation of the filtered and unfiltered tabular Kraken reports for all the sam-
ples.
Table 3.4: Information on the seven FMDV samples sequenced at the NCFAD
Sample Top BLAST Hit (GenBank Accession) % Query Coverage % Identity
A A IRN 2005 (EF494486) 97 99
O O UKG/11/2001 (DQ404180) 95 99
C C KEN/1/2004 (KM268897) 97 99
Asia1 Asia1 Shamir/89 (JF739177) 100 99
SAT1 SAT1 KEN (JF749860) 99 93
SAT2 SAT2 ZIM/7/83 (AF540910) 99 92
SAT3 SAT3 ZIM/4/1981 (KX375417) 99 99
3.3.6 CLARK analyses
The objective of the first analysis performed with CLARK was to classify publicly avail-
able FMDV genomes at the serotype level. This was performed by searching the sequences
in the KC-testing reference target database with CLARK. The first CLARK analysis involved
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the classification of complete, publicly available FMDV genomes, and it was performed by
using KC-testing database. Briefly, hash sketches of the KC-testing database and the KC-
training database were generated with mash sketch and the Mash distances between the
KC-testing and the KC-training database were generated with mash dist. Results were
filtered to remove all the data with Mash distances equal to 1 (maximum dissimilarity). Af-
ter that initial filter, the top 5 results for each accession number that had more than 8 hashes
shared with the KC-training database were kept.
The analyses of NGS data with CLARK (version 1.2.4) were performed using a
snakemake workflow in the computer cluster of the NML starting with the concatenated
forward and reverse FASTQ files of each sample as inputs (Figure 3.3). The same custom
database that was used to create the Kraken database (KC-training) was used for building
the CLARK target database. Since species is the lowest taxonomic level at which CLARK
performs classifications, a custom target list was built using the GenBank accession num-
bers and the NCBI Taxonomy ID of the seven FMDV serotypes for each sequence in the
database.
The second CLARK analysis involved the classification of the seven FMDV samples se-
quenced at the NCFAD vs. the KC-training database. Two CLARK modes were compared
in all the CLARK analysis: full and default. CLARK′s full mode offers higher sensitivity by
loading all discriminative k-mers in memory and providing a confidence score for all the
classifications, while the default mode is less sensitive, although it has a faster execution, it
is precise, and uses less Random Access Memory (RAM) than the full mode.
3.3.7 MinHash-based analyses
A MinHash-based approach (mash) was tested in the following series of analyses:
the classification of complete and partial publicly available FMDV genomes (KC-testing
database), and the classification of the NGS samples sequenced at the NCFAD (n=7) by
pairwise comparison of MinHash sketches ofall the samples. A snakemake workflow was
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Figure 3.3: Diagram of the CLARK classification snakemake workflow which included
the classification of concatenated forward and reverse FASTQ files for each sample (rule
concat_fastq) with CLARK version 1.2.4 using the default mode (parameter -m 1; rule
clark_default). Classification was followed by the estimation of serotype abundances
using the getAbundance script of CLARK. A second workflow with the same structure was
used for classifying reads with CLARK′s full mode (parameter -m 0). This diagram is a
representation of the directed acyclic graph (DAG) of targets and dependencies used in this
workflow, and the box labeled as “all” represents the final target of workflow, which is the
generation of the serotype abundance estimation CSV files for all the samples.
designed and implemented for processing the seven FMDV samples sequenced at the NC-
FAD with mash version 2.0 in the computer cluster of the NML (Figure 3.4).
3.3.8 Identification of serotype-specific SNPs
For this SNP analysis, a multiple sequence alignment (MSA) of complete genomes
was generated as the reference for discovering unique SNPs that distinguish the different
FMDV serotypes. The training set was generated by aligning 298 FMDV complete genome
sequences (SNP-training database; Table 3.1) with ClustalX 2 (Larkin et al., 2007). The
workflow contained rules for signature discovery, analysis, and prediction for the differen-
tiation between different groups of foot-and-mouth disease virus sequences.
Single nucleotide polymorphisms were identified using a Python script (developed by P.
Krusckewicz; material unpublished) in which the presence or absence of a SNP at a given
position of the MSA was converted to a binary code (1 = present, 0 = absent). The statistical
analysis of the association of SNPs with metadata categories was performed with feht
(Laing, 2017). This program written in Haskell was used for analyzing the differences in the
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Figure 3.4: Diagram of the Mash snakemake workflow. This diagram is a representation
of the dependency graph of rules used in this workflow, and targets are not depicted for the
purpose of saving space. This workflow included the generation of reference sketches from
the same dataset used for the kraken and CLARK analyses (rule mash_reference_sketch).
Rules were also designed and implemented for the following steps: generating sample Mash
sketches (rule mash_sample_sketch), calculating the Mash distances between samples and
reference, calculation of containment, and pairwise Mash distances from the comparisons
of all the samples.
proportion of SNPs between different metadata groups with Fisher’s exact test. The results
were corrected for multiple comparisons using the Bonferroni multiple-testing correction.
In this analysis, feht was used to find highly sensitive and highly specific markers for the
prediction of metadata groups. The feht program reported all the pairwise comparisons
between groups, as well as the comparisons between each group and the combination of
all the other groups. For example, feht reported the comparison between all serotype A
sequences against all sequences that are not serotype A (i.e. the combination of serotypes O,
C, Asia1, SAT1, SAT2, and SAT3). The null hypothesis in feht is that markers are present
in equal proportions in both of the groups that are being compared. The null hypothesis was
rejected when a marker is present or absent at a significantly higher proportion (alpha=0.05)
in a group than in the combination of the other groups. For the purposes of this study, only
SNPs that were present in all the sequences of a serotype and absent from all the sequences
of all the other serotypes were used for the generation of SNP profiles.
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To evaluate the robustness of the detected SNPs new sequences were aligned with Py-
NAST (Caporaso et al., 2010), which aligns new sequences to an existing MSA without in-
troducing new gaps. This allowed the comparison of the serotype-specific bases to the new
sequences introduced with the PyNAST alignment of new or unknown sequences. Compar-
isons between the bases identified in the reference alignment and the new PyNAST-aligned
sequences were performed with the R statistical computing language (R Core Team, 2016)
using the seqinr package (Charif and Lobry, 2007) to read the multiple sequence align-
ments and to convert them into matrices. The nucleotide positions identified with feht were
used for comparing the SNPs identified in the reference alignment vs. the alignment of new
sequences. If the bases at each position were identical, a value of 1 was computed and a
value of 0 if they were not identical. Those profiles were used for identifying serotypes
based on specific SNPs.
3.4 Results
3.4.1 Classification of publicly available genomes
3.4.1.1 Performance of microarray probes for the in silico classification of new
strains
Previously designed oligonucleotides were analyzed to test how predictive those signa-
tures were for the characterization of the serotypes of new sequences that were not evalu-
ated for the development of the electronic microarray assay presented in chapter 2. In this
in silico analysis, the probes from three microarray assays were analyzed with an updated
database (OE). The evaluation of the probes from three different studies revealed that the
probes in the microarray study presented in this thesis detected all the sequences in the up-
dated database, while the probes from the study by Watson et al. (2007) were less sensitive
(Table 3.5).
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Table 3.5: BLAST and e-PCR results of pan-FMDV probes versus only those sequences
in the Oligonucleotide Evaluation database that contain the common region (n=368/500).
Numbers in parenthesis represent the number of unique sequences correctly detected and
the total number of sequences of that particular serotype. The threshold for BLAST hits
was 80% coverage, and the e-PCR searches were performed by evaluating hits as 0, 1, 2, 3,
4, and 5 mismatches. The study by Wang et al. (2002) did not include pan-FMDV probes.
This study Watson et al. (2007)
Target Serotype BLAST e-PCR BLAST e-PCR
A 100.0 (91/91) 78.0 (71/91) 70.3 (64/91) 70.3 (64/91)
O 100.0 (175/175) 89.7 (157/175) 81.1 (142/175) 81.1 (142/175)
C 100.0 (9/9) 100.0 (9/9) 66.7 (6/9) 66.7 (6/9)
Asia1 100.0 (19/19) 47.4 (9/19) 47.4 (9/19) 47.4 (9/19)
SAT1 100.0 (29/29) 96.6 (28/29) 72.4 (21/29) 72.4 (21/29)
SAT2 100.0 (35/35) 100.0 (35/35) 77.1 (27/35) 71.4 (25/35)
SAT3 100.0 (10/10) 90.0 (9/10) 30.0 (3/10) 20.0 (2/10)
Table 3.6: BLAST and e-PCR results of querying serotyping probes versus the entire
Oligonucleotide Evaluation database (n=500). Probe sequences were obtained from 3 dif-
ferent studies. the numbers inside the parentheses represent the number of unique sequences
correctly subtyped and the total number of sequences of that particular serotype.
This study Watson et al. (2007) Wang et al. (2002)
Target Serotype BLAST e-PCR BLAST e-PCR BLAST e-PCR
A 93.8 (105/112) 93.8 (105/112) 93.8 (105/112) 69.6 (78/112)
O 96.3 (180/187) 98.4 (184/187) 93.6 (175/187) 89.3 (167/187) 94.1 (176/187) 82.4 (154/187)
C 88.9 (8/9) 77.8 (7/9) 77.8 (7/9) 77.8 (7/9) 100.0 (9/9) 100.0 (9/9)
Asia1 100.0 (20/20) 100.0 (20/20) 100.0 (20/20) 100.0 (20/20)
SAT1 75.0 (60/80) 76.2 (61/80) 73.8 (59/80) 37.5 (30/80)
SAT2 100.0 (77/77) 96.1 (74/77) 72.7 (56/77) 31.2 (24/77) 45.5 (35/77) 36.4 (28/77)
SAT3 100.0 (15/15) 100.0 (15/15) 80.0 (12/15) 60.0 (9/15)
3.4.1.2 Identification of signatures with Neptune
Neptune identified sequence signatures with high specificity and sensitivity for distin-
guishing each FMDV serotype. Although, as expected, many of these markers were located
in the VP1-encoding region of the FMDV genome, there were other regions identified in
non-traditional sites for serotype determination such as the 5’ UTR, the 3C protease, or the
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3A nonstructural protein (Table 3.7). The top sequence signatures found for serotypes A,
C, and SAT1 were 100% sensitive and 100% specific to those serotypes (score = 1.0), while
sequence signatures discovered for serotypes O (score = 0.8750), Asia1 (score = 0.7609),
SAT2 (score = 0.9341), and SAT3 (score = 0.9670) had lower scores, representing a trade-
off between sensitivity and specificity. Signature length ranged from 91 base pairs to 4104
base pairs.
Table 3.7: Sequence signatures obtained with Neptune for differentiation of FMDV strains
vs. all the other serotypes. The score is a combined measure of sensitivity and specificity,
and the size is the number of base pairs of the sequence signatures.
Serotype Score Size (bp) Product
A
1.0 595 3C protease
1.0 676 5’ UTR
1.0 559 L protease
1.0 415 3A nonstructural protein
1.0 133 5’ UTR
1.0 4104 Polyprotein
0.9930 2839 Polyprotein
O
0.8750 104 VP1
0.8744 223 VP1
0.8724 243 VP1
0.8587 92 VP1
0.8582 268 VP1
C
1.0 91 VP1
1.0 93 VP1
1.0 76 VP1
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Table 3.7: Sequence signatures obtained with Neptune for differentiation of FMDV strains
vs. all the other serotypes. The score is a combined measure of sensitivity and specificity,
and the size is the number of base pairs of the sequence signatures.
Serotype Score Size (bp) Product
1.0 88 VP1
Asia1
0.7609 138 VP1
0.7434 152 VP1
0.7093 375 VP1
0.6118 85 VP1
SAT1
1.0 84 VP1
0.8968 155 VP1
0.8954 239 VP1
SAT2
0.9341 744 P1 polyprotein
0.8793 174 VP1
0.8790 124 VP1
0.8526 251 VP1
SAT3
0.9670 424 3A
0.9000 150 VP1
0.8723 188 VP1
0.8636 110 VP1
3.4.1.3 Classification of publicly available genomes with Kraken
In silico analyses were performed using kraken to characterize publicly available
complete genomes and NGS reads. The first experiment involved using the MiniKraken
database to classify 298 complete FMDV genome. In that analysis, 283 sequences were
classified (94.97%), and 15 sequences were left unclassified (5.03%). The 283 sequences
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that were classified by Kraken were correctly categorized as FMDV, but all of those 283
sequences were incorrectly classified as serotype O. Those results are explained by the
fact that there was only one FMDV sequence in RefSeq at the moment this analysis was
performed, and it was the complete genome of a serotype O strain from the 1997 Taiwan
outbreak (GenBank accession number NC_004004).
In the second Kraken analysis with the database that included partial sequences and
complete genomes, 2,076 sequences were classified out of 2,086 sequences (99.52% sensi-
tivity), and 10 sequences (0.48%) were unclassified. Further investigation of the 10 unclas-
sified sequences revealed that those 10 sequences are from vaccine patents, or from other
chimeric sequences that were classified as FMDV in the NCBI taxonomy database. Out of
the classified sequences, the classified serotype was correct for 2,003 sequences (96.48%
specificity). In addition, there were 15 sequences that were characterized as FMDV but
which were not further classified as any of the serotypes.
3.4.1.4 Classification of publicly available genomes with CLARK
Working on default mode, CLARK classification resulted in the correct serotype assign-
ment of 2041 of 2086 (97.84%) of the publicly available sequences that were classified,
only 45 sequences were not classified. However, that number was reduced to 38 sequences
when working with the full mode of CLARK. Notably, three serotype sequences were de-
tected with full mode which were not detected with the default mode (Table 3.8).
3.4.1.5 Classification of publicly available genomes with Mash
Classification of publicly available sequences was performed by using mash dist to
calculate the Mash distance between the KC-testing database and the KC-training database.
3.4.1.6 Search and validation of serotype-specific SNPs
SNP markers that had 100% sensitivity and 100% specificity (ratio of 1.0) were found
for the seven FMDV serotypes analyzed with the SNP-training database. The SNP profiles
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Table 3.8: Classification of KC-testing database with CLARK. Two CLARK methods were
compared: the default mode and the more computationally expensive full mode.
Target Serotype % Subtyped - Default % Subtyped - Full
A 20.81 (434) 20.81 (434)
O 51.97 (1084) 51.97 (1084)
C 0 0.14 (3)
Asia1 7.53 (157) 7.53 (157)
SAT1 5.37 (112) 5.56 (116)
SAT2 11.65 (243) 11.65 (243)
SAT3 0.53 (11) 0.53 (11)
Unknown 2.16 (45) 1.82 (38)
Table 3.9: Summary of Mash classification results
Query Serotype Percent Covered
A 98.2 (431/439)
O 99.6 (1077/1081)
C 71.4 (5/7)
Asia1 100.0 (161/161)
SAT1 93.8 (105/112)
SAT2 90.6 (221/244)
SAT3 76.9 (10/13)
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found in this study can be used as signatures to identify new strains that were not in the
original alignment. In the approach used in this study, the SNP profiles were generated
by comparing the SNPs of the reference FMDV whole genome sequence alignment vs.
an alignment of the new sequences built with PyNAST using the reference alignment as
a template. Comparisons were performed at the positions that were identified with the
feht statistical tool as specific to the group in question. This method resulted in binary
profiles that were highly discriminatory of the seven serotypes in the in silico experiments
performed for this study.
The SNP profiles had different numbers of discriminatory SNPs for each serotype, and
these discriminatory positions were present in the range from position 2121 to position 4156
of the reference alignment Table 3.10. These positions are various sites in the polyprotein
region of the FMDV genome.
The SNP genotyping method here described was able to classify correctly 100%
(391/391) of the sequenced downloaded from ViPR that were not part of the original align-
ment with which the SNP profiles were determined. There was only one case in which the
binary profile matches less than half of positions of the target sequence (Figure 3.5g). In
that case, the serotype SAT3 profile matched only 15/34 of the UGA/1/13 strain (GenBank
Accession KJ820999). The other three serotype SAT3 strains ZIM/4/1981 ( KX375417),
KNP/10/90 (KR108950), and ZIM/6/91(KM268901) were matched by 32, 32, and 34 SNPs
of the SAT3 profile. In addition, the two serotype SAT3 strains (FV536932 and FV536933)
present in the "unidentified" pool of 53 genomes were matched by 26/34 SNPs of the SAT3
profile.
When tested with sequences that had not been in the previous alignment, the method
identified the serotypes of 391 FMDV complete genomes Figure 3.5. There were 53 acces-
sions in the testing data set of which ViPR or NCBI did not identify a serotype or in which
the curators likely did not include the serotype information. These sequences were used
as "blind" test cases to assess the accuracy of the SNP markers in characterizing the seven
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serotypes of FMDV. The SNP genotyping method here described correctly identified the
serotype of 100% of the uncharacterized sequences. Further investigation of the accession
numbers and the metadata present in Genbank (i.e. record titles or notes in the sequence
features) further confirmed the 100% sensitivity and specificity of the characterization of
the serotypes of these genomes.
Table 3.10: Number, p-values, and positions in the reference multiple sequence alignment
MSA of serotype-specific SNPs. The SNPs were located in the regions of the FMDV
genome encoding for the VP4, VP2, VP3, and VP1 peptides. All the SNPs in this table
were found to be present in 100% of the genomes of eachserotype, and absent from 100%
from the other serotypes. P-values were calculated using the Fisher’s Exact Test with feht
(Laing, 2017). The reference MSA file and a list of the GenBank accession numbers for
each genome sequence used in the alignment can be accessed in https://github.com/
ropolomx/fmdv_snp_analysis.
Serotype Number of SNPs P-value Positions in reference MSA
A 6 1.22×10−68 2277, 2293, 2721, 3739, 3846, 4114
O 9 1.29×10−84 2298, 2359, 2385, 2398, 2685, 3251, 3444, 3960, 4129
C 5 1.82×10−29 2292, 2293, 3898, 3940, 3941
Asia1 13 2.69×10−46 2121, 2292, 2293, 2386, 2574, 2746, 2779, 3013,
3024, 3030, 3031, 3807, 4059
SAT1 25 4.38×10−13
2151, 2289, 2314, 2401, 2506, 2664, 2728, 2743, 2997,
3039, 3040, 3175, 3178, 3256, 3422, 3798, 3841,
3916, 3918, 3919, 3922, 3937, 4026, 4035, 4104
SAT2 34 2.14×10−8
2289, 2290, 2296, 2691, 2700, 2721, 2742, 2749, 2758,
2922, 2935, 2938, 3072, 3178, 3310, 3341, 3353,
3366, 3369, 3377, 3379, 3380, 3419, 3492, 3542,
3680, 3753, 3765, 3772, 3790, 4033, 4135, 4137, 4156
SAT3
36
6.14×10−5
2226, 2227, 2289, 2314, 2371, 2395, 2448, 2458, 2469,
2526, 2581, 2713, 2751, 2752, 3027, 3039, 3040,
3057, 3081, 3354, 3392, 3428, 3437, 3591, 3598,
3742, 3744, 3799, 3825, 3843, 3978, 3982, 4034,
4039, 4105, 4148
3.4.2 Classification of NGS data
3.4.2.1 Kraken analysis
In the Kraken analysis the NCFAD NGS samples were classified against the reference
database. This analysis resulted in more complex results than the previous two experiments.
The majority of reads of the serotype A, Asia1, O, SAT1, and SAT2 samples corresponded
to the correct serotype. However, in the case of the SAT3 sample, the classification of sam-
ples was very close between the SAT3 (n=1,197,219 reads; 38.54% of input reads), and
98
3.4. RESULTS
(a) Serotype A-specific SNPs
(b) Serotype O-specific SNPs
Figure 3.5: Presence and absence of serotype-specific SNPs in (a) serotype A and (b) serotype
O FMDV genomes. The heatmaps represent the presence and absence of serotype-specific SNPs
in genomes of the seven FMDV serotypes. SNP positions from the reference alignment are in the
y-axis,and isolates are in the x-axis. Blue colour represents that the base at the position in the
alignment of the new sequences is identical to the base in the reference alignment, and white colour
represents that the base at the position in the alignment of the new sequences is not identical to the
same position in the reference alignment. The "NA" category represents 53 genomes that did not
have an assigned serotype in the ViPR database. This figure continues in the next three pages with
results for the other 5 serotypes.
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(c) Serotype C-specific SNPs
(d) Serotype Asia1-specific SNPs
Figure 3.5: Presence and absence of serotype-specific SNPs in (c) serotype C and (d)
serotype Asia1 FMDV genomes.
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(e) Serotype SAT1-specific SNPs
(f) Serotype SAT2-specific SNPs
Figure 3.5: Presence and absence of serotype-specific SNPs in (e) serotype SAT1 and (f)
serotype SAT2 FMDV genomes.
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(g) Serotype SAT3-specific SNPs
Figure 3.5: Presence and absence of serotype-specific SNPs in (g) serotype SAT3 genomes.
SAT1 serotypes (n=1,151,282 reads; 37.06% of input reads). Two potential explanations
for the apparently low specificity is the presence of low-quality classifications in Kraken’s
results, or classifications where the reads of multiple individual k-mers were split between
SAT1 and SAT3 serotypes. This hypothesis was evaluated by using the kraken-filter
program to filter the classifications based on Kraken’s scoring method with two filtering
scores assessed 0.05 and 2 (Figure 3.6). The filtering of the classification at the threshold
of 0.05 did not show a considerable difference in comparison to the unfiltered classifica-
tion, while the classification at the confidence score threshold of 2 lead to a reduction of
sensitivity and a decrease in specificity.
3.4.2.2 CLARK analysis
This analysis involved the classification of the 7 NGS NCFAD samples using filtered
fastq reads, and many reads were not identified as unique to each serotype, which is consis-
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Figure 3.6: FMDV serotype classification of NCFAD samples with Kraken. Kraken as-
signments were performed after running kraken followed by the filtration of low quality
assignments with kraken-filter at two different filtration thresholds: 0.05 and 0.2. The
proportions of classified reads without using kraken-filter after assignment with kraken
were also reported (Not Filtered).
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tent with the observations seen in Kraken that many reads were stranded at the species level
(i.e. only classified as FMDV and not classified further). A potential explanation for this is
that there are many k-mers that are common between all the FMDV serotypes and only a
fraction of those are specific to each serotype. In the case of the classification of the serotype
C NCFAD sample, using the default mode resulted in the identification of assignments to
other serotypes. However, using the default mode resulted in a mis-characterization of the
sample as a mostly SAT2 sample. In the case of the SAT2 NCFAD sample, the classifi-
cation at the default mode resulted in the assignment to the SAT1 and SAT3, while there
was an increase of the proportion of reads that were classified as SAT2 in comparison to
the proportion of reads classified as SAT1. In the case of the SAT3 sample, there was an
increase in the proportion of reads classified as SAT3 in comparison to the reads classified
as SAT1 Figure 3.7.
3.4.2.3 Mash analysis
The objective of this analyses was to classify seven FMDV NGS samples into the seven
FMDV serotypes by usingmash, an implementation of the MinHash algorithm for bioinfor-
matics. In this analysis the k-mer sketches of the NCFAD FMDV samples were classified
against a reference k-mer sketch built with publicly available databases and the reads were
screened for containment (mash screen) versus the same reference database, and pairwise
comparisons of all the sample NGS k-mer sketches were performed.
Plotting the screening or the analysis of containment of the NGS samples versus the
reference database resulted in two types of signals in the data: the presence of multiple
query hits that match more than one serotype, and the high sensitivity of Mash to detect
each of the serotypes Figure 3.8. Using this approach resulted in the accurate classification
of the seven NGS samples representing the seven serotypes. The pairwise comparison of
the Mash sketches also showed that the NGS datasets representing the seven serotypes
were differentiated by using mash, and that the three southern African serotypes are closer
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Figure 3.7: FMDV serotype classification of NCFAD samples with CLARK. Two modes
of the CLARK software were tested: default and full. The proportions of classified reads
for the results of both modes were reported.
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Figure 3.8: Screening of FMDV NGS samples with Mash. Seven NGS samples sequenced
at the NCFAD were screened versus a reference database Mash sketch. The blue colour
scale represents the identity proportion between query and reference sketches. White colour
represents absence of results (i.e. there were no hits reported between the NGS sample
query and a given strain in the reference sketch).
to each other than to the other serotypes, which resembles what has been observed from
analyses of nucleotide and protein sequences (Figure 3.9).
3.5 Discussion
3.5.1 Evaluation of existing oligonucleotides
Updating microarray assays is particularly challenging for those assays that target ss-
RNA viruses because of the rapid evolution of those viruses. However, oligonucleotides
that were designed for the detection of viruses or subtypes of viruses have the potential to
be used in new microarray assays in new platforms or as in silico signatures with NGS data
provided they are sensitive and specific with updated database. The research question ad-
dressed in this analysis was: what is the sensitivity and specificity of the serotype-specific
probes against new sequences in the FASTA format database? The pan-FMDV (or detec-
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Figure 3.9: Heatmap of the pairwise Mash distances between the seven samples sequenced
at the NCFAD. The mash dist tool was used to calculate the Mash distances between these
datasets in a pairwise fashion.
tion) probes used in this study detected all the sequences in the updated database, while
the probes in the older study by Watson et al. (2007) were less sensitive. In the case of the
serotype-specific probes, the performance of the probes from the electronic microarray as-
say presented in this thesis was superior to the sensitivity of the other two studies. Notably,
the performance of the serotype C probes from the ViroChip study by Wang et al. (2002)
outperformed the probes from this thesis and from the study by Watson et al. (2007). How-
ever, the serotype SAT2 probes from the ViroChip study were outperformed by the probes
in this study and the study by Watson et al. (2007). Those results suggest that the sensitivity
of probes designed in older studies may decrease with updated databases, and that the in
silico coverage of new strains of FMDV may not be as effective with oligonucleotides de-
signed for older studies. As more NGS data becomes available through the Sequence Read
Archive (SRA) NCBI and in GenBank, more in-depth analysis is required to evaluate the
sensitivity of detection and subtyping probes.
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3.5.2 Signature discovery with Neptune
The analysis with Neptune resulted in the discovery of serotype-specific sequence sig-
natures of various sizes. These signatures can potentially become amplicon targets for
discriminatory assays (i.e. a multiplex RT-PCR assay for discriminating between the
serotypes), because the sequence signatures are sensitive and specific to the serotypes, and
those regions can be used to design molecular assays to differentiate between the serotypes,
which includes the design of oligonucleotides. More comprehensive validation is required
in order to assess how predictive these signatures are for the detection and characterization
of FMDV strains not present in the training database used in this study. Refining this analy-
sis with the improvement of the training database can results in the generation of signatures
that are more appropriate for in silico and in vitro analysis. Another potential application
of Neptune to FMDV genomics in particular and viral genomics in general
3.5.3 K-mer based taxonomic classification methods
Kraken is one of the most widely used taxonomic classifiers of metagenomic datasets.
Kraken is a fast tool due to the fast k-mer counter jellyfish. Interestingly, the
kraken-filter option is a tool of this software that is not widely used and there are few
entries in the literature that use it. One of the authors mentioned that they were looking
for a different method to filter low-quality assignments (Salzberg, S., 2017, personal com-
munication). Tools that were designed to improve on Kraken such as Bracken (Lu et al.,
2017) and the recently developed KrakenHLL can potentially promise to further refine the
assignments done with kraken. These results suggest two possibilities: (1) that there is
more than one serotypes present in the same sample, or (2) that kraken does not have the
sufficient precision or specificity for the classification of FMDV subtypes. In regards to the
first possibility, the implementation of de novo metagenomic assembly could be useful for
generating evidence of whether there are strains of more than one serotype present in the
sample in the samples. Then, the comparison of those assemblies to the Kraken classifica-
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tion could confirm if the assignments are correct. In the second case, an expansion of the
reference database may improve to accurately predict the serotype of newer sequences.
In this series of k-mer based analyses, the taxonomic classification tool called CLARK
was also used to classify FMDV sequences by serotypes. Similarly to kraken, CLARK
(Ounit et al., 2015) classifies draft assemblies (in FASTA format) or sequencing reads (in
FASTQ format) using k-mer profiles. In contrast to kraken, CLARK classifies reads only at
one taxonomic level at a time. Two modes of this software were tested: default and full. The
authors of CLARK reported that it was the fastest taxonomy classifier in the benchmarking
tests they ran (Ounit et al., 2015). Considering that CLARK accepts FASTQ files as input, this
approach may be suitable for characterizing the serotypes of unassembled, pre-processed
NGS, and the implementation of this tool in the workflows of regulatory laboratories has
the potential to make the determination of FMDV serotypes much more efficient.
Recently, alignment-based taxonomic classifiers such as centrifuge (Kim et al.,
2016), or the protein sequence based kaiju (Menzel et al., 2016) can be potentially im-
plemented for the identification of in silico signatures of FMDV serotypes. For instance, a
recent study by Walsh et al. (2018) found that kaiju is one of more suitable tools for the
analysis of the composition of low-complexity communities. Moreover, kaiju can be po-
tentially applied to the detection of unknown viruses thanks to its translation of nucleotide
sequences to amino acid sequences. Since amino acid sequences are more conserved than
DNA sequences, this can improve sensitivity of detection. This functionality is also present
in the newest version of Kraken (Kraken 2).
3.5.4 Mash-based classification of serotypes
The classification of publicly available genomes using mash dist to calculate the Mash
distance showed great promise in the classification of the KC-testing database. Mash is a
computational technique that is faster than typical approaches such as BLAST, and its im-
plementation in bioinformatics is gaining more adoption for the rapid characterization of
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the serotypes of pathogens and the characterization of metagenomes. The pairwise compar-
isons of the NGS samples performed with Mash revealed that sequences are much closer
to each other. Serotypes A, O, C, and Asia1 have shorter distances to each other than to
the three SAT serotypes. Although Mash was not designed explicitly for reconstructing
phylogenies, it can be used to approximate phylogenies rapidly by applying hierarchical
clustering to Mash distances (Ondov et al., 2016).
3.5.5 Serotype-specific SNPs of FMDV
In this study, SNPs that were statistically associated with FMDV serotypes were discov-
ered using an approach that relies on multiple sequence alignments. To the author’s knowl-
edge, this study is the first time that barcodes of serotype-specific SNPs have been proposed
for the foot-and-mouth disease virus. The SNP barcoding method here utilized shares some
similarities to the strategy of oligotyping proposed by Eren et al. (2013) for amplicon-based
microbial community profiling. In oligotyping, a profile or barcode is generated with SNPs
that minimize the entropy between ecological groups of interest (i.e. SNPs that are present
in one groups but absent in another).
From a bioinformatics point of view, a key aspect of the method here presented is the
utilization of the pyNAST alignment software (Caporaso et al., 2010). pyNAST is often
used in 16S microbial community profiling, such as in the QIIME package, when new 16S
sequences are added to existing 16S alignments such as Greengenes, or SILVA. pyNAST
returns an alignment with the same positions as the template. The alignment of new se-
quences to the reference alignment can be improved by generating a reference alignment
with more complete genomes. This can increase the confidence in the validation of SNPs
in new strains. Further characterization of the SNPs identified in this thesis is required,
such as the precise annotation of the SNPs in a reference genome and the determination of
whether the SNPs represent synonymous or non-synonymous mutations.
FMDV is notable for its highly variable genomes, and the concept of quasispecies was
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developed by researchers who studied this virus (Domingo et al., 1985, 1992). The identifi-
cation of these unique SNPs could become the basis for designing detection and subtyping
assays. For example, oligonucleotides can be designed for genotyping assays based on a
single SNP. An example of this is the primer extension assay developed by Spizz et al.
(2012), in which SNPs were targeted for warfarin genotyping. In the case of FMDV, this
could potentially allow for assays that require less oligonucleotides for serotyping due to
a relative small number of stable SNPs being targeted. This could potentially mean that
the number of probes in an microarray chip or card can be less than what was used for the
electronic microarray assay reported in chapter 2. An interesting follow up to the search of
serotype-specific SNPs would be the search of topotype-specific SNPs. The rapid identifi-
cation of topotypes in field isolates has the potential to provide more in-depth knowledge
of the molecular epidemiology of the virus during outbreak conditions. Validation of the
SNPs found in this work would be required to consider them suitable for assay design or
for the study of FMDV evolution.
3.5.6 Future directions
The identification of group-specific signatures is important for the characterization of
pathogens and the understanding of their evolution. Although the robust SNPs here pre-
sented can be adapted as markers and targets of real-time PCR assays, the subtle nucleotide
variation of FMDV quasispecies could be further characterized using other approaches.
Another aspect to reflect upon the SNP analysis is that the robust SNPs here discovered are
based on consensus sequences. If the goal is to characterize of FMDV quasispecies, this
could be potentially performed with specialized tools such as ViQuaS (Jayasundara et al.,
2015) which uses a reference-guided de novo assembly approach for building local haplo-
types. ViQuas was tested with two FMDV datasets from the same sample and it outper-
formed similar tools in strain reconstruction. Other software tools for quasispecies charac-
terization such as quasitools(https://github.com/phac-nml/quasitools/), which
111
3.5. DISCUSSION
is currently applied to the analysis of HIV quasispecies, could be potentially adapted and
applied to the analysis of FMDV quasispecies and viral drug resistance. Another approach
that can potentially be useful for studying the genetic diversity of quasispecies of the same
FMDV serotype is the application of oligotyping (Eren et al., 2013) to the genomes or VP1
sequences of isolates from different geographical locations, different outbreak events or
points in time. The oligotyping approach applies a technique known as minimum entropy
decomposition (Eren et al., 2015) to multiple sequence alignments of NGS reads in order
to find SNPs that differentiate ecologically important groups.
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Conclusions and future prospects
The consequences of the contagious nature of FMDV in the agricultural sector of the many
countries where this virus is or has been present have shaped international livestock trade
and animal welfare policies. The entry of transboundary and emerging diseases of animals
such as FMDV into Canada is a risk for which the design and implementation of science-
based solutions are required. The collection of useful information by Canada’s animal
health authorities during an outbreak situation is central to Canada’s emergency response to
mitigate the consequences for the agricultural sector. The characterization of the subtypes
of FMDV field strains informs the selection of FMDV field vaccine. Given that Canada
is, along with the United States of America, and Mexico, one of the owners of the North
American FMDV antigen bank, obtaining this information quickly will be critical during
an outbreak event. The contribution of this thesis to the detection and classification of
FMDV serotypes is the development and initial validation of the first electronic microarray
assay for the simultaneous detection and serotyping of FMDV. Furthermore, this work has
explored the classification of FMDV serotypes of NGS and publicly available data and the
generation of a novel SNP genotyping approach for the classification of FMDV serotypes.
These approaches can be potentially applied to the classification of the subtypes of other
viruses such as avian influenza virus.
As more regulatory and research laboratories adopt next generation sequencing for di-
agnostics and surveillance, innovations in sequencing technologies have resulted in the de-
velopment of portable and field-deployable instruments that have the potential to be used
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for the detection of viral pathogens of humans and animals in the field as outbreaks occur,
including foot-and-mouth disease virus (Freimanis et al., 2016). One of those innovative
sequencing technologies is the Oxford Nanopore MinION sequencer. This technology in-
volves the reading of changes in ionic current due to base-specific fluctuations while DNA
goes through a protein channel (Wang et al., 2015b).
Examples of viruses sequenced with the Oxford Nanopore include an avian influenza
genome (Wang et al., 2015a), the real time genome sequencing during the 2015 Ebola
outbreak in West Africa (Quick et al., 2016), and the discovery of porcine kobuvirus for
the first time in Belgium (Theuns et al., 2018). Nanopore technologies are promising for
the global surveillance of viruses in the field because the portability of the MinION in
combination with global positioning system global positioning system (GPS) technologies
can enable high-resolution tracking of viruses such as FMDV which can provide better
support for tracing the spread of the virus (Freimanis et al., 2016).
Beyond the applications of nanopore sequencing for whole genome sequencing, the
potential application of metagenomic sequencing for the identification of viral pathogens
in clinical samples with a MinION sequencer was reported in the study by Greninger et al.
(2015). In that study, sequencing followed by cloud-based basecalling of nanopore reads
and real-time bionformatics analysis with the metaPORE pipeline was achieved in less than
6 hours. Using that method, Ebola virus, chikungunya virus, and hepatitis C virus were
detected from human blood samples. The metaPORE pipeline is an adaptation of another
metagenomic pathogen detection and discovery pipeline: SURPI (Sequence-based Ultra-
Rapid Pathogen Identification) (Naccache et al., 2014). The SURPI pipeline was notably
applied to the diagnosis of neuroleptospirosis with Letospira santarosai of a 14-year patient
with meningoencephalitis where other diagnostic methods including magnetic resonance
imaging, brain biopsy, and multiple PCR tests for different bacterial and viral pathogens
did not reveal the causative pathogen (Wilson et al., 2014). Its innovations included the use
of a fast nucleotide aligner called SNAP (Zaharia et al., 2011) and a fast aminoacid aligner
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called RAPSearch (Zhao et al., 2012) that accelerated the processing time of the analysis of
metagenomic samples. In that clinical case, 475 sequence reads derived from the patient’s
cerebrospinal fluid were mapped to the Leptospira borgpetersenii genome which was the
closest match, and appropriate treatment was then prescribed by the medical care personnel
in charge of the patient. Also, taxonomic classifiers such as the k-mer based approaches
explored in chapter 3 (Kraken and CLARK), as well as alignment-based classifiers (e.g.
Centrifuge) and other classification approaches that translate NGS reads and search them
against an aminoacid sequence database (i.e. kaiju and kraken 2).
Generating whole genome sequences not only facilitates the work of regulatory agencies
and research laboratories in understanding the molecular epidemiology of viruses such as
FMDV, but it also opens the door to other applications related to the control of the virus.
For instance, a critical step in the control of FMD is matching vaccines to field isolates
(Paton et al., 2005), which is usually performed with serological methods such as ELISA.
In the study by Reeve et al. (2010), predictions of vaccine matching and identification of
antigenic variability were made based on genomic sequencing in computational work which
also showed the presence of three epitopes for FMDV SAT1 for the first time in this case.
One of the main results from that study was the performance of vaccine matching using
sequence data was superior to the performance of serology. This work involved statistical
modeling using a linear mixed-effects model to estimate r1 values from serological data (i.e.
the ratio of antibody titre of reference serum against field isolates to the titre of reference
serum against vaccine strains). The model also used sequence-based predictors, accounted
for phylogeny-based effects, and individual areas and residues were added to this model
to identify epitopes, as well as within-serotype diversity. This work allowed the prediction
of the best vaccine match for any foot-and-mouth disease virus and the coverage of new
vaccine candidates from their capsid sequences (Reeve et al., 2010).
Another important development in FMDV genomics research that has the potential to
expand the current understanding of the epidemiology and the pathology of the disease is
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the application of NGS for the characterization of quasispecies during outbreak events For
example, the characterization of the genetic variation of FMDV at the host and the herd lev-
els allowed to identify sequences not only at the consensus level, but at the sub-consensus
level when studying the transmission of the virus between farms in samples from the UK
2007 outbreak (King et al., 2016) The work by Wright et al. (2011) showed that the ap-
plication of NGS to the analysis of viral populations within two bovine epithelial samples
showed intermediate evolution stages in the replication of the virus and evolutionary dy-
namics at a higher resolution. Using NGS for studying viral quasispecies can help to un-
derstand sequences that are related and understand the genetic variation of populations at
each site (Wright et al., 2011).
The work in this thesis explored laboratory and in silico methods for the characteriza-
tion of FMDV serotypes. The techniques and methods here presented could also be ap-
plied to other viruses, or to other epidemiological groups of interest for FMDV researchers
(e.g. topotypes). Although additional validation work is required for the electronic microar-
ray assay and the in silico analyses, the work here presented lays a foundation for the uti-
lization of primers and probes for detection and characterization of FMDV. The refinement
and expansion of training sets used in the in silico analyses will help to improve the per-
formance of the classification of NGS reads of FMDV. Some of the approaches discussed
in this chapter could also help to detect animal pathogens from metagenomic sequencing
in cases where other diagnostic tests have failed to reveal what is the possible causative
pathogen.
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Appendix A
Supplementary methods from Chapter 2
A.1 Design of synthetic constructs
The work described in this section was performed by staff of the Lethbridge Labo-
ratory of the National Centres for Animal Disease (CFIA), in particular by Kimberley
Burton Hughes (now with Agriculture and Agri-Food Canada). Nineteen synthetic
DNA constructs were synthesized by Integrated DNA Technologies (IDT; Coralville, Iowa,
USA) by using pGEM3Zf(+) plasmids (Promega P2271) as vectors for the cloning of the
1.2 Kb inserts (Lung et al., 2011). The constructs were designed using sequences from
vaccine strains and representative strains for each serotype after reviewing the quarterly
reports of the World Reference Laboratory for FMD where recommendations of FMDV
strains to be added to antigen banks are often included (The Pirbright Institute, Pirbright,
Surrey, UK). In some cases, the sequences of certain strains that are available in Genbank
are partial and belong to a smaller portion of the target region ( 600 bp). In other cases,
no sequences were available in GenBank for the desired strain. In both types of those
cases, the most closely related complete genome sequences available were used to generate
backbones to complete to 1.2Kb sequences.
A.2 Viral propagation and viral RNA extraction
The work described in this section was performed by staff of the vesicular disease
unit of the National Centre for Foreign Animal Disease (CFIA; Winnipeg, Manitoba)
and Lethbridge Laboratory staff in Winnipeg. The twenty-three viruses used for initial
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laboratory validation of the electronic microarray assay were propagated in primary lamb
kidney (PLK) cells. Viral RNA was extracted using TriPure reagent (Roche Diagnostics
Canada), and the RNA pellets were suspended in 25µL of DEPC-treated water and stored
at −80◦C. Total RNA was extracted from the FMDV-infected cells as described by Lung
et al. (2011).
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